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Abstract
Cardiovascular disease is one of the leading causes of death in Canada. Arterial stiffness is
an important factor in the pathogenesis of cardiovascular disease. Cardiac failure, hyperten-
sion, renal failure, and dementia have all been linked to arterial stiffness. The arterial system
is designed to dampen the pulses of blood from the heart’s left ventricle and distribute the
blood forward as steady flow in the small vessels. The pulse-dampening ability of the arterial
system is reduced with age when the elastic fibers in the arterial wall degrade and fracture.
The arterial stiffening process can accelerate from deposition of minerals within the arterial
wall, such as calcium, from the endothelial layer becoming compromised or from fibrosis
secondary to inflammation or turbulence. Arterial stiffness can be assessed post-mortem
by microscopic examination of the arterial wall. However, for use in dynamic experiments
and for therapeutic intervention, several ante-mortem techniques have been developed: pulse
wave velocity (PWV), pulse waveform analysis (PWA), wave separation analysis (WSA), and
carotid ultrasonography. Rats are important models for cardiovascular disease, toxicology,
and pharmacological studies because of their convenient size and short life cycle. However,
PWA and WSA have not been shown to be valid approaches for studying arterial stiffness
in rat peripheral arteries. In this thesis, dynamic in vivo methods for PWA and WSA in rat
peripheral arteries were developed to provide accurate measures of arterial stiffness. Software
specific to the rat vasculature, PWanalyze and WSanalyze, was developed to measure PWA
and WSA parameters, respectively. A comparison of these PWA and WSA methods in rat
peripheral arteries was performed by creating a range of arterial stiffnesses through acute
and chronic experiments. Arterial stiffness was measured in the femoral artery by a novel
PWA parameter, the minimum time derivative of blood pressure (dP/dtmin), as effectively
as the established parameter the maximum time derivative of blood pressure (dP/dtmax). A
new method of WSA in femoral arteries was developed. Backward wave amplitude measured
in the aorta was shown to increase as arteries stiffened and decrease as arteries relaxed with
acute vasoactive drug injections. These experiments showed that dP/dtmin and WSA are
valid approaches to use when studying arterial stiffness in rats.
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Chapter 1
Introduction
1.1 Main Theme and Overall Structure
This thesis explores novel methods of measuring arterial stiffness in the rat and the cardio-
vascular hemodynamic principles supporting these methods. The motivation of this thesis
is to address a major problem in preclinical biomedical science. There are many algorithms
and indicators of arterial stiffness developed for humans that are not yet adapted to animal
models, putting preclinical biomedical researchers at a major disadvantage because of a dis-
connect with human clinical end-points. The current methods of measuring arterial stiffness
in rats are inadequate because they rely on multiple assumptions and their results are not
easily reproducible between laboratories. To fill this gap in knowledge, this thesis presents
two novel methods using intra-arterial blood pressure traces. Two independent studies were
conducted. The first study investigates how the the rate at which blood pressure changes
within an artery is related to arterial stiffness. The maximum rate of change of decreasing
blood pressure, i.e., the minimum time derivative of blood pressure, dP/dtmin, was shown
to be a novel indicator of arterial stiffness in addition to an established indicator of arterial
stiffness, the maximum rate of change of increasing blood pressure, the maximum time deriva-
tive of blood pressure, dP/dtmax. The second study showed that wave separation analysis
(WSA) could be used to assess wave reflections in the peripheral arteries. Wave reflections
were demonstrated in the femoral artery with backward wave amplitude being a sensitive
indicator of acute changes in arterial stiffness using vasoactive drug injections.
Chapter 2 is a data chapter introducing the novel dP/dtmin parameter for measuring
acute and chronic changes in arterial stiffness. Chapter 3 provides a theoretical overview of
the mathematical and physical principles that are the necessary background information for
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wave separation analysis. Chapter 4 is a data chapter describing wave separation analysis
in rats and the acute changes in wave reflections that occur in rats. Chapter 5 is a final
discussion of the results, scientific contributions, and directions for future work.
1.2 Arterial Stiffness and Cardiovascular Disease
Epidemiological studies have demonstrated that arterial stiffness is associated with increased
morbidity and mortality in humans [53, 96]. Cardiovascular disease accounts for a third of
all deaths in the US and Canada [2, 27, 119]. Diseases caused by arterial stiffness include
cardiac failure [67] and small vessel disease [96] of the kidney and brain leading to renal
failure and dementia [10, 52, 82]. Arterial stiffness is a potential cause and consequence of
hypertension [49]. Arterial stiffness causes hypertension through increased wave reflections
as discussed in Section 1.3 [53]. Hypertension causes arterial stiffness by increased vascular
smooth muscle cell hypertrophy and damage to the elastic components of the arterial wall [21].
Establishing a link between arterial stiffness and cardiovascular disease requires knowledge
of the mechanical properties of arteries.
The central arteries have elastic properties; hence, arterial mechanics is based on the
theory of elastic materials [88]. The ability of a solid material to return to its original shape
after being deformed is defined as elasticity. The force used to stretch an elastic material over
a unit distance is referred to as the elastic modulus [88]. The elastic modulus is a relative
measure of the quantity of force required to stretch an elastic material. The elastic modulus
in a longitudinal direction is called Young’s modulus [88]:
E =
Longitudinal force per unit area
Extension per unit length
. (1.1)
Stiff arteries have a large elastic modulus, whereas distensible arteries have a small elastic
modulus. A stiff artery takes more force to stretch the same amount as a distensible artery.
There are two major proteins which form the structure of the arterial wall: collagen and
elastin. The collagen and elastin fibers partly determine the distensibility of the arterial wall
along with endothelial cell function, vascular smooth muscle tone, and mineralization with
calcium and phosphorus [139].
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Predisposing factors that cause arterial stiffness include inflammation, hypertension, ag-
ing, and toxicity. Inflammation and hypertension both stimulate excessive collagen produc-
tion, damage to elastin fibers, hypertrophy of vascular smooth muscle, and decreased normal
elastin [139]. Age-related changes can also cause elastic structural protein damage, trans-
ferring stress on the arterial wall from elastin to collagen fibers [7, 55]. The collagen fibers
have a higher elastic modulus than elastin fibers contributing to an overall stiffening of the
arterial wall [91]. The degradation of elastin fibers from aging or inflammation is associated
with increased calcification in the medial layer of the arterial wall [3, 79, 139]. Section 1.5
discusses arterial stiffness from toxicity relevant to the rodent model species used in this
thesis.
A common example of arterial stiffening arises in elderly people, where the proximal aorta
can be stiff from fracture of the elastin fibers [91]. Elastin has a half-life of decades; once
it is damaged, the stress of each pulse is transferred to rigid collagenous components of the
arterial wall [88]. The elastic modulus of the artery increases from elastin damage [88]. The
force generated by blood ejection from the left ventricle dilates a stiff proximal aorta less
than a distensible proximal aorta. Therefore, a stiff proximal aorta causes increased left
ventricular load [91]. The heart compensates for increased load by increasing myocardial
mass (hypertrophy), reducing capacity for filling with blood during diastole. Predisposition
to myocardial ischemia and cardiac failure are consequences of increased metabolic demands
of a hypertrophied, chronically loaded heart with reduced blood filling during diastole [91].
This reduced diastolic filling then causes the heart to stimulate its contractile force to increase
heart rate to maintain cardiac output and creates a positive feedback mechanism leading to
further myocardial hypertrophy and reduced blood filling during diastole [91]. Myocardial
hypertrophy compromises the heart muscle perfusion during diastole, leading to myocardial
ischemia [91]. Additionally, a stiff aorta is unable to dampen the pulsatile force from the
heart, causing the pulsatile energy to propagate down the arterial system. This pulsatile
energy damages the small vessels in vasodilated organs with vulnerable vascular beds (such
as the kidney and brain) causing renal failure and dementia [10, 52, 82, 88].
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1.3 Wave Reflection in the Arterial System
The arterial system can be thought of as a tree of distensible tubes, through which blood
travels throughout the body. Blood movement throughout the body is characterized by three
properties: pressure, flow, and resistance. Blood pressure is the force the blood exerts on the
walls of an artery. Blood flow is the rate of movement of blood through an artery. Resistance
is the opposition to blood flow through an artery.
Pressure waves and flow waves describe the manner in which blood pressure and blood
flow pulse with each heart beat. The pressure and flow waves travel through the arterial
system. At any variance in this system of arteries, such as a narrowing or branching of an
artery, part of the wave travelling from the heart is transmitted forward past the variance
and the remaining fraction is reflected backwards [88].
The closed-end tube model is a simplified model of the arterial system used to explain
wave reflection, shown in Figure 1.1. The closed-end tube model of the arterial system is
comprised of a long elastic tube filled with liquid, where liquid is pushed into the end of
the tube, representing the heart ejecting blood. The other end is closed, representing the
resistance to blood flow at a branch point or narrowing of the arterial tree [15, 88]. For each
heart beat, the pressure generated against the tube edges that travels down the tube is called
the forward pressure wave, Pf . Once the pressure wave reaches the closed end of the tube,
it is reflected back in a pressure wave, Pb.
In 1956, Wetterer hypothesized that the pressure and flow waves measured in the arterial
system were the sum of forward travelling waves from the heart and backward travelling waves
returning from peripheral variances in the arterial system [88]. These forward and backward
waves have been shown experimentally using both electrical and hydraulic models. In the
electrical models, voltage has analogous behaviour to blood pressure and current has equiv-
alent analogous to blood flow. Taylor experimentally showed that electrical and hydraulic
models were mathematically equivalent when he compared an electrical transmission line to
a single tube subject to sinusoidal fluid flow, the closed-end tube model [118, 117]. Jager et
al. clarified the mathematics between the transmission line model and the arterial system
by presenting similarities between the telegraph equations and the linearized Navier–Stokes
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Figure 1.1: The closed-end tube model of the arterial system, adapted from Mc-
Donald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles,
Nichols, W.M. et. al., 6th edition, 2011, Hodder Arnold, London [88]. The heart ejects
blood into the left side of a long elastic tube. For each heart beat, the pressure gener-
ated against the walls of the tube propagates down to the closed right side in a forward
travelling pressure wave. Once the forward travelling pressure wave reaches the closed
end of the tube, it is reflected backwards. The resulting backward travelling pressure
wave sums with the forward travelling pressure wave generated by the subsequent heart
beat.
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equations [50]. The telegraph equations describe the transmission line and the linearized
Navier–Stokes equations describe fluid flow. The telegraph and linearized Navier–Stokes
equations are given in Appendix A and are shown to be analogous. The calculations for
separating pressure and flow waves into their forward and backward travelling components
were first outlined for a canine ascending aorta but now have been applied to humans, swine,
and rabbits [57, 71, 88, 133]. The calculations from the canine study have been adapted to
rat arteries in this thesis [133].
1.3.1 Wave Reflection Increases with Arterial Stiffness
Properties of the arterial system, including arterial stiffness, determine the amplitude and
the velocity of propagation of the backward wave [88]. The amplitude of the backward wave
is increased for stiff arteries. The velocity of propagation of the backward wave is increased
for stiff arteries causing it to arrive during late systole, rather than diastole [88]. An example
of age-related change in backward wave velocity between a father and his son is shown in
Figure 1.2. The 68 year-old father has augmentation of aortic systolic blood pressure (SBP)
from early backward wave arrival and the 37 year-old son has arrival of the backward wave
during diastole [92]. The 68 year-old father has stiffer arteries than his 37 year-old son because
of age-related degradation of the elastic components of his arteries. Stiffer arteries lead to
negative cardiovascular outcomes including cardiac hypertrophy, rising blood pressure, and
damage to vasodilated organs. This thesis examines methods of measuring arterial stiffness
for basic science research on these cardiovascular outcomes.
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Figure 1.2: Radial (left) and aortic (right) pressure waves in a 36-year-old man (top)
and his 68-year-old father (bottom) calibrated to the same brachial cuff values of systolic
and diastolic blood pressure. Reprinted from the Journal of the American College of
Cardiology, Volume 50, O’Rourke, M. F., and Hashimoto, J., Mechanical Factors in
Arterial Aging: A Clinical Perspective, 1-13, Copyright (2007), with permission from
Elsevier.
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1.4 Measurement of Arterial Stiffness
Presently, there are several accepted approaches to measuring arterial stiffness: pulse wave ve-
locity (PWV), pulse waveform analysis (PWA), wave separation analysis (WSA) and carotid
ultrasonography [88, 127]. Pulse wave velocity uses the transmission speed of the pulse wave-
form as a direct measure of arterial stiffness. Pulse waveform analysis analyzes the shape
of the measured pulse waveform, Pm, to indicate arterial stiffness. Wave separation analysis
calculates wave reflection in the arterial system to indicate arterial stiffness. Wave separa-
tion analysis involves calculating Pf and Pb; it is also commonly referred to as impedance
analysis. Pulse waveform analysis is the study of the shape of a pressure pulse, particularly
the upward slope of each pulse, and does not involve separating the pressure pulse into for-
ward and backward components. Carotid ultrasonography assesses structural changes in the
arterial wall at the common carotid artery and its bifurcation [127]. The following sections
discuss the principles, advantages, and disadvantages of these approaches in detail.
1.4.1 Pulse Wave Velocity
Pulsatile force increases with pulse wave velocity, which is the speed of the pressure wave
travelling forward along an artery [88]. As the elastic modulus of the arterial wall increases,
so does the pulse wave velocity by the Moens–Korteweg equation [88]:
PWV =
√
Eh
2Rρ
(1.2)
where E is the elastic modulus of the artery defined in Equation 1.1, h is the thickness of
the arterial wall, R is the arterial radius, and ρ is the density of blood. In practice, pulse
wave velocity is experimentally measured to obtain elastic modulus from Equation 1.2 [69].
Pulse wave velocity is measured by two methods: foot-to-foot transmission speed and local
arterial imaging [69, 127].
The foot of a wave is usually defined as the end of diastole, where the upstroke from systole
begins [69, 88]. The foot-to-foot transmission speed involves measuring a pulse wave at two
separate locations, most commonly the right carotid and right femoral artery and calculating
the time delay between the feet of the two waves [69, 127]. In other studies, different reference
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points have been used to determine the time delay between waves [39, 97, 98], but these
methods have been contested due to effects of wave reflection on the wave shape [40, 88, 134].
Pulse wave velocity is calculated by:
PWV =
D
∆t
,
where D is the distance of the two arteries measured externally in meters and ∆t is the time
delay measured between the feet of the two waves [69]. The most common technique for
measuring pulse wave velocity is the carotid-femoral foot-to-foot method [127].
An alternative approach to measure pulse wave velocity involves arterial imaging. Local
arterial imaging using Doppler ultrasound or magnetic resonance imaging can be used to
directly measure the local pulse wave velocity at an artery [37, 69, 75, 77]. One method of
locally measuring pulse wave velocity is through measuring transit-time (TT). Transit-time
is the time it takes for the pulse to travel from the heart to the area of arterial imaging.
The pulse departing the heart is denoted by the ECG-R wave indicating ventricular con-
traction and the pulsed wave doppler upstroke indicates the arrival of the pulse at the area
of arterial imaging. Transit-time does not have the same requirement of measuring the dis-
tance travelled by the pulse. Transit-time also has the added advantage that it only requires
imaging one arterial site at a time and a simultaneous ECG trace. However, transit-time is
only comparable between subjects when measured at the same arterial site in similar sized
subjects. Transit-time is used in this thesis because it can be measured non-invasively and
instantaneously in a time-sensitive drug injection experiment.
Pulse wave velocity measured at the carotid artery is desirable because the carotid artery
is a common site of atherosclerotic plaque formation [12, 69]. However, local pulse wave
velocity measured at the aorta is more accurate for patients with diabetes or hypertension [94].
Additionally, the magnitude of pulse wave velocity can be decreased in the carotid artery
compared to the aorta due to decreased blood flow to the brain [64]. Both carotid and aortic
pulse wave velocity have been shown to increase with concurrent cardiovascular disease and
to predict risk of cardiovascular mortality in humans [32, 64, 68, 121, 123, 126]. However,
the knowledge of whether these measures have the same predictive power in experimental
animal models is unclear. Thus, the goal of this thesis is to examine and validate the use of
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these measures in rodent models.
Pulse wave velocity is the gold standard for measuring arterial elasticity and, subsequently,
arterial stiffness [69, 81, 125, 127]. The advantage to using pulse wave velocity is that it can
be measured directly by ultrasound, whereas pulse waveform analysis and wave separation
analysis derive arterial stiffness parameters through a model of the arterial system. The
disadvantage to using pulse wave velocity to indicate arterial stiffness is that it varies with
heart rate and blood pressure in multiple species [14, 66, 107, 115, 136].
1.4.2 Pulse Waveform Analysis
Pulse waveform analysis can be used as an indicator of arterial stiffness. Traditional and
novel indicators of stiffness derived from pulse waveform analysis are explored in Chapter 2.
Pulse waveform analysis uses the shape of the pressure waveform to infer arterial stiffness and,
subsequently, the risk of cardiovascular disease and cardiovascular mortality. Currently used
pulse waveform analysis parameters include diastolic blood pressure (DBP), systolic blood
pressure, pulse pressure (PP), dP/dtmax, and augmentation index (AIX). In the following sec-
tion, Figure 1.3 illustrates the parameters of diastolic blood pressure, systolic blood pressure,
pulse pressure, and dP/dtmax, and Equation 1.3 explains how to calculate AIX. The shape of
the measured pressure wave varies by anatomic location as illustrated in the representative
arterial locations in Figure 1.2. Therefore, parameters of arterial stiffness measured from the
shape of the pressure wave vary by anatomic location as well. For example, systolic blood
pressure and pulse pressure measured invasively at central arteries have been shown to be
better indicators of arterial stiffness than measured non-invasively at peripheral arteries [88].
Arterial stiffness has been associated with changes in pulse waveform analysis parameters:
diastolic blood pressure, systolic blood pressure, pulse pressure, dP/dtmax, and AIX.
Diastolic blood pressure, the nadir of the pressure pulse, is also dependent on arterial
stiffness, peripheral resistance, and cardiac output [87]. An increase in arterial stiffness
decreases diastolic blood pressure; a stiff arterial wall stores less potential energy during
blood ejection from the heart [87]. The diastolic blood pressure decreases due to less potential
energy from the arterial wall converting to kinetic energy during diastole [87]. In contrast, an
increase in either peripheral resistance or cardiac output causes an increase in diastolic blood
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pressure [87]. A decrease in diastolic blood pressure is seen in older patients with age-related
arterial stiffness where wave-reflections have caused the backward wave to arrive during
systole rather than diastole [30, 73, 76, 124]. An increase in diastolic blood pressure is used
to indicate cardiovascular morbidity and mortality in young subjects where the strain on the
heart is from increasing peripheral resistance rather than age-related arterial stiffening [73,
76, 124].
Systolic blood pressure, the peak of the pressure pulse, is dependent on arterial stiffness,
peripheral resistance, and cardiac output [87, 88]. An increase in arterial stiffness increases
systolic blood pressure by two different mechanisms: decreased force dampening from the
central arteries and increased wave reflection. Systolic blood pressure rises when the central
arteries are less able to convert the kinetic energy from blood ejection into potential en-
ergy [87]. Additionally, increased arterial stiffness increases the magnitude and transmission
velocity of the backward pressure wave that causes an increase in systolic blood pressure
because the backward pressure wave arrives during systole [87]. Similar to diastolic blood
pressure, systolic blood pressure also increases with cardiac output and peripheral resis-
tance [87, 88]. Systolic blood pressure is used as an indicator of the need for therapeutic
intervention and to indicate cardiovascular morbidity and mortality [104, 112, 113, 137].
Pulse pressure is the difference between systolic blood pressure and diastolic blood pres-
sure. Pulse pressure also increases with increasing arterial stiffness and can be used as an
indicator of stiffness [88]. There are conflicting studies on whether pulse pressure is supe-
rior to systolic blood pressure in predicting cardiovascular morbidity or mortality [9, 61, 84].
Central arterial pulse pressure is a better indicator of arterial stiffness and predictor of car-
diovascular morbidity and mortality in older adults [88].
The maximum time derivative of the pressure pulse waveform, dP/dtmax, has been used
as a measure of arterial stiffness in peripheral arteries [4, 33, 34, 35]. In central arteries,
dP/dtmax is used as a measure of left ventricular contractility [13].
The arteries stretch to accommodate the blood pushed by each contraction of the heart in
systole. In diastole, the arteries recoil back to their original size. The portion of the pressure
pulse waveform in diastole, the downward slope, occurs between peak systolic blood pressure
and base diastolic blood pressure. The shape of the downward slope of the pressure pulse
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waveform is influenced by the elastic recoil of the artery and presence of backward waves.
The downward slope of the pressure pulse waveform is neglected in pulse waveform analysis
because of the variation in shape imposed by the presence of backward waves; however,
the steepest section of downward slope, dP/dtmin, could represent the maximum elastic
recoil ability of the artery. In Chapter 2, the minimum time derivative of the pressure pulse
waveform, dP/dtmin, is proposed as a novel measure of arterial stiffness in peripheral arteries.
dP/dtmin could be a better indicator of arterial stiffness than dP/dtmax because the elastic
recoil of the artery occurs in a passive portion of the cardiac cycle, diastole, where the active
contraction of the heart does not have a direct effect.
AIX, a measure of wave reflection, increases with arterial stiffness and predicts cardiovas-
cular morbidity independent of peripheral pulse pressure [125]. AIX measures the boost in
late systolic blood pressure from the backward wave arrival expressed as a percentage:
AIX =
AP
SBP−DBP × 100, (1.3)
where AP is the amplification pressure. AP represents the increase in pressure measured by
the difference in amplitude of the systolic blood pressure and forward pressure wave (Af )
shown in Figure 1.3. The forward pressure wave height is estimated by an inflection point
that indicates the arrival of the backward wave. The inflection point is defined as the second
peak of the second derivative of the pressure wave, is denoted as Pinfl in the literature, and
is shown in Figure 1.3 [88]. AP is calculated by:
AP = SBP− Pinfl.
In human medicine, AIX is used to estimate of the size of the backward wave based on a well-
known blood pressure wave shape [88]. Generally, AIX is measured in the aorta but several
studies have measured AIX in peripheral arteries with conflicting results [72, 114]. Aortic
AIX is influenced by many factors: heart rate, aortic taper, body length, and left ventricular
ejection [38, 88]. In this thesis, the blood pressure data were collected from the carotid and
femoral arteries in rats did not meet the shape requirements to measure AIX. Therefore,
other pulse waveform analysis parameters are vital tools for basic science research in arterial
stiffness. Chapter 2 explores pulse waveform analysis parameters in rats, including a new
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Figure 1.3: Schematic blood pressure waveform showing measured (Pm), forward
(Pf ) and backward (Pb) arterial pressure waves, systolic blood pressure (SBP), dias-
tolic blood pressure (DBP), amplification of the pressure pulse (AP), amplitude of the
forward pressure wave (Af ), amplitude of the backward pressure wave (Ab), and max-
imum time derivative of pressure (dP/dtmax, i.e., the slope of the increase in pressure
with each pulse). The arrival of the backward wave is estimated by a change in systolic
upstroke pressure called the inflection point (Pinfl). Reflection index (RI = Ab/(Af+Ab)
) and augmentation index (AIX= AP/(SBP − DBP ) × 100) can be calculated from
AP, Af , and Ab.
proposed pulse waveform analysis parameter, the minimum time derivative of the pressure
pulse waveform, dP/dtmin.
1.4.3 Wave Separation Analysis
Wave Separation Analysis can be used to derive indices of arterial stiffness. The use of wave
separation analysis is novel in rats and thus will be explored in Chapter 4. Wave separation
analysis involves the calculation of forward and backward pressure waves from a measured
pressure wave [127]. The forward and backward pressure waves can be calculated from a
measured pressure wave if there are simultaneous flow waves also measured or estimated
in the same animal [132]. Flow is needed along with pressure in wave separation analysis
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in order to calculate characteristic impedance (Zc), which is a measure of the resistance at
an artery immediately distal to the measuring site to pulsatile blood flow. Characteristic
impedance is defined as the ratio of oscillatory pressure to oscillatory flow assuming no wave
reflections are present [133]. Determining the characteristic impedance at an artery is the
first step in the calculation of forward and backward waves. Once the forward and backward
waves are calculated, their ratio, the reflection index (RI), can be used as a measure of arterial
stiffness. Chapter 3 describes the mathematics of wave separation analysis in detail.
Wave separation analysis parameters include Zc, RI, and backward pressure wave am-
plitude. Wave separation analysis parameters are not interchangeable with pulse waveform
analysis parameters. For example, RI has a better predictive ability for adverse cardiovascular
morbidity and mortality than AIX [127]. Wave separation analysis parameters that quantify
the degree of wave reflection, backward pressure wave amplitude, and RI are recommended
vascular biomarkers for predicting cardiovascular morbidity and mortality [127, 129].
Zc is used to determine the stiffness of an artery immediately distal to the measuring
site [88]. Zc increases as an artery becomes stiff. If an artery diameter increases, Zc de-
creases [88]. The characteristic impedance of the aorta is also used as a measure of left
ventricular after-load, that is, the pressure the left ventricle must contract against to eject
blood [88]. The characteristic impedance of peripheral arteries is a measure of the difficulty
for the blood to pass through that artery [88]. In rodents, Zc has been measured in the
aorta to study cardiovascular disease [67, 80, 105]. This thesis proposes a new approach in
Chapter 4 that allows Zc measurement in the carotid and femoral arteries of a rat. There
are multiple methods to calculate Zc. These methods and the details of the specific method
used to calculate Zc are complex. Due to the complexity of the Zc derivation, Zc is not as
favoured as a measure of arterial stiffness compared to pulse waveform analysis. Chapter 3
in this thesis is devoted entirely to detailing the method used in this thesis for Zc calculation.
Chapter 3 will not be a publication, but it is necessary to understand in detail the contents
of Chapter 4, a manuscript examining wave separation analysis use in a rat model.
RI represents the ratio of the backward wave to the measured wave and is calculated by:
RI =
Ab
Af + Ab
,
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where Ab is the amplitude of the backward pressure wave and Af is the amplitude of the
forward pressure wave. Reflection index has been shown to be predictive of cardiovascular
mortality in men but not in women [129].
Reflected pressure amplitude measures the magnitude of the wave reflections. Reflected
pressure amplitude has been shown to be an indicator of arterial stiffness, cardiovascular
morbidity, and mortality, independent of gender [127, 129].
The manuscript in Chapter 4 outlines wave separation analysis in the rat. A method in
rats for calculating Zc has been outlined [80] and is currently in use [24, 105].
1.4.4 Carotid Ultrasonography
Carotid ultrasonography involves directly imaging the common carotid artery using transcu-
taneous ultrasound in greyscale (B-mode) and Doppler modes [36]. The two main carotid
ultrasonography parameters are the carotid intima-media thickness (cIMT) and carotid peak
systolic velocity (CA PSV) [99].
cIMT is the distance between the intimal and adventitial arterial wall layers measured
transcutaneously with grey scale ultrasonography [127]. cIMT measures the local atheroscle-
rosis of the carotid artery and is used a surrogate measure of generalized atherosclerosis [127].
CA PSV is a measure of the peak velocity of blood through the carotid artery [36]. CA
PSV is a measure of the narrowing of the carotid artery, carotid artery stenosis, that occurs
with carotid plaque formation and increased cIMT [99].
Carotid ultrasonography is widely used to evaluate arterial stiffness and cardiovascular
morbidity because it is non-invasive and relatively inexpensive [36, 99, 127]. However, there
are many inconsistencies in ultrasound examination protocol [36]. Within the same labora-
tory, extreme care must be taken to follow a consistent protocol for all carotid ultrasound
examinations. In this thesis, CA PSV was measured to give a general measure of the degree
of carotid artery stenosis throughout the carotid artery.
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1.5 Rats as a Model Species for Cardiovascular Toxi-
cology and Pharmacology Studies
The ideal animal model for translational cardiovascular research mimics human pathophysi-
ology and develops the same end-stage disease as humans [103]. Economically, it is desirable
for an animal model to be small with a short lifespan; however, the animal model must be
large enough to perform the desired measurements to be practical [103].
Rodents and lagomorphs are important models for cardiovascular disease. Arterial stiff-
ness has been assessed in rats for many pathophysiological states, including aging, left ven-
tricular hypertrophy, hypertension, calcification of arteries, chronic renal failure, and dia-
betes [18, 19, 24, 44, 67, 90, 105]. Normal rats, mice, and rabbits are resistant to atheroscle-
rosis [103]. A variety of genetic strains of rats (i.e., Zucker Diabetic Fatty, spontaneously
hypertensive rats, and cp/cp ), mice (i.e., APoE-/- and LDLR-/-) and rabbits (i.e., watan-
abe heritable hyperlipidemic and Kurosawa and Kusanagi-Hypercholesterolemic) have been
developed to model the abnormal metabolism associated with atherosclerotic disease in hu-
mans [54, 103].
Atherosclerosis can also be induced in common strains of rodents and lagomorphs. Rab-
bits are sensitive to a high cholesterol diet and will develop atherosclerotic lesions in response
to increased cholesterol in the diet [103]. Atherosclerosis has also been induced in normal
rats and mice for toxicology and pharmacology studies with high cholesterol diets, and excess
vitamin D in combination with nicotine [22, 45, 51, 103]. Vitamin D given as a single agent
has a variety of effects on the vascular system. Vitamin D has a protective effect on the
arterial system by suppressing inflammatory processes [140]. Deficiency of vitamin D leads
to an inflammatory state where the arterial system is predisposed to atherosclerotic plaques
of activated endothelial cells and vascular smooth muscle cells [140]. However, vitamin D
given in excess causes calcification of the arteries [140]. In this thesis, rodents with a variety
of levels of vitamin D supplementation were used to study methods of measuring arterial
stiffness because of the range in arterial stiffness created.
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1.5.1 Arterial Stiffness Measurement in Rats
Pulse wave velocity has been used to measure arterial stiffness in the rat, using both inva-
sive and non-invasive methods [14, 81]. Measuring pulse wave velocity with two catheter-tip
manometers placed in the aorta and the foot-to-foot time delay method has highly repro-
ducible results in rats [81]. This invasive technique has been used to verify that pulse wave
velocity is heart rate and pressure dependent in rats [14, 115]. Non-invasive techniques for
measurement of pulse wave velocity in rats involve using doppler ultrasound and simulta-
neously recorded ECG to calculate transit speed of the pulse over a known distance [83].
Chapter 2 uses non-invasive pulse wave velocity to measure arterial stiffness.
The pulse waveform analysis parameter AIX has been used to study arterial stiffness in a
rat model of type 2 diabetes; however, AIX was calculated with the software SphygmoCor 8.0
(AtCor Medical, Sydney, Australia) that is developed and verified for the human radial
artery [6, 78]. AIX has also been calculated in rats by inspection of the return point of the
backward wave in central aorta pressure recordings [89]. In this thesis, AIX was not measured
because the blood pressure data collected from the carotid and femoral arteries in rats did not
have the required pulse waveform shape. The pulse waveform analysis parameter, dP/dtmax,
has been used as a measure of arterial stiffness in toxicology studies in rats [33, 34, 35]. A
novel pulse waveform analysis parameter dP/dtmin is investigated in rats in Chapter 2.
Wave separation analysis has been used to verify that a new advanced glycation inhibitor,
LR-90, prevented arterial stiffening and to investigate the effect of nitric oxide on the arte-
rial system [16, 43, 105]. The use of wave separation analysis parameters, characteristic
impedance, reflection index, and wave transit time were verified by histological examination
of the rat aorta in two independent studies [24, 105]. Accumulation of advanced glycation
end products were observed in rats that also had increased reflection index and wave tran-
sit time [24, 105]. These advanced glycation end products bind and induce alterations on
proteins and lipid structures of the arterial wall [24, 105]. Once advanced glycation end prod-
ucts are bound to the arterial structures they interact with their receptor (RAGE) that cause
arterial stiffening through reactive oxygen species generation and activation of the immune
response [24, 105]. Additionally, left ventricular hypertrophy has been shown to occur in
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rats with artificially increased wave reflection through surgical aorta narrowing [60]. A novel
technique for performing wave separation analysis in rats is presented in Chapters 3 and 4.
The technique will allow measurement of characteristic impedance, backward wave ampli-
tude, and reflection index in the peripheral arteries for improved understanding of arterial
stiffness in dynamic cardiovascular studies in the rat.
Carotid ultrasonography has been used in rats to investigate the risk of early salt exposure
on hypertension and stroke risk and the effects of arterial injury on arteriosclerosis [28,
62]. Spontaneously hypertensive rats fed a high-fat diet have been used to verify cIMT
measurements captured by high-frequency ultrasound against carotid artery intima thickness
measured by histology [23]. CA PSV has been used as a measure of blood flow and an
indicator of shear stress through the carotid artery in rats after arterial injury [62]. More
commonly, CA PSV is used to indicate carotid artery stenosis [36]. In Chapters 2 and 4, CA
PSV is used to measure arterial stiffening, which causes a stenotic-like condition.
1.5.2 Blood Pressure Measurement in Rats
Blood pressure in rats can be measured by a variety of techniques: tail cuff oscillimetry,
implantable telemetry, and intra-arterial catheterization. Of these three techniques, intra-
arterial catheterization is the gold standard of blood pressure measurement [95].
Tail cuff oscillimetry is the indirect measurement of blood pressure at the tail artery by an
oscillemetric cuff [42]. Tail cuff oscillimetry blood pressure is highly variable with rat body
temperature [42]. During tail cuff oscillimetry, the rectal temperature of the rat must be
kept between 34 ◦C and 36 ◦C for five minutes to obtain an accurate measurement of blood
pressure [42]. If direct blood pressure is measured, the rats can be normothermic during blood
pressure measurement [42]. Variability between tail cuff oscillimetry and direct blood pressure
measurement of systolic blood pressure has been reported to be as high as 34 mmHg [63].
Tail cuff oscillimetry is recommended for detecting substaintial group differences in systolic
blood pressure and systolic blood pressure changes in large numbers of animals [65]. Tail
cuff oscillimetry is not recommended for measuring diastolic blood pressure or pulse pressure
and therefore was not used in this thesis [65].
Implantable telemetry directly measures blood pressure by an implantable radio trans-
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mitter [46]. Implantable telemetry is desirable for chronic, continuous blood pressure mea-
surement and has an added advantage that rats do not have to be restrained or anaesthetized
during data collection [46]. The blood pressure data from implantable telemetry are accurate
enough to study subtle changes in blood pressure [65]. A disadvantage of implantable teleme-
try is that it involves a surgical procedure with a prolonged surgical recovery time, possibility
of significant complications, and the possibility that catheters can lose their patency over long
studies [48]. The largest roadblock for researchers that want to use implantable telemetry is
the expense and labour associated with using this technique compared to other methods (tail
cuff oscillimetry, intra-arterial catheterization) [65]. In this thesis, implantable telemetry is
used to investigate pulse waveform analysis parameters dP/dtmin and dP/dtmax in conscious,
unrestrained rats.
Intra-arterial catheterization is the direct measurement of arterial blood pressure using a
heparinized saline-filled catheter attached to a pressure transducer or Millar solid-state high-
fidelity catheter [95]. The disadvantage to intra-arterial catheterization is that it involves
a surgical procedure that is usually performed under anesthesia and is often terminal [48].
Millar catheters are preferred over heparinized saline-filled catheters because heparinized
ssaline-filled catheters are subject to errors from variable damping due to air micro-bubbles
in the catheter [88]. Millar catheters were used in this thesis to study wave separation analysis
because they will not introduce artificial errors into the wave separation analysis algorithm
due to dampening.
1.6 Study Rationale
This thesis conducts two studies intended to increase the information available in the field of
cardiovascular preclinical biomedical science pertaining to arterial stiffness. The first study in
Chapter 2 presents a novel measure of arterial stiffness, dP/dtmin. The validity of dP/dtmin as
a measure of arterial stiffness is investigated with chronic changes in arterial stiffness through
a rodent model of vitamin D deficiency and vitamin D excess. Radio-telemetry is used
to obtain accurate 24-hour blood pressure measurements in conscious unrestrained rats for
the study. The responsiveness of dP/dtmin for acute changes in arterial stiffness is also
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assessed by vasoactive drug injection in anesthetized rats. The goal of the first study is to
provide a sensitive measure of arterial stiffness in rats where intra-arterial blood pressure
is measured. The second study presents a novel technique for measuring wave separation
analysis parameters that indicate arterial stiffness. The aim of the novel technique is to
measure wave separation analysis parameters in easily accessible arteries such as the femoral
artery. The wave separation analysis algorithm is outlined, developed, and tested against
a known dataset in Chapter 3. The surgical portion of the novel wave separation analysis
technique is validated in normal male Wistar rats in an acute vasoactive drug injection
experiment in Chapter 4. The goal of the second study is to add wave separation analysis to
the arsenal of tools available to preclinical biomedical researchers to ensure human clinical
end-points reflect those obtained in preclinical biomedical research. Human clinical end-
points are based on non-invasive pulse wave analysis techniques developed to estimate arterial
stiffness in the central arteries that have not been validated in a rodent models [6]
1.7 Research Hypotheses
This thesis investigates the following hypotheses:
1. Chronic changes in the vascular wall can be measured by dP/dtmin. A increase in
arterial stiffness will cause an increase in magnitude of dP/dtmin.
2. Acute changes in the vascular wall can be measured by dP/dtmin. A increase in arterial
stiffness will cause an increase in magnitude of dP/dtmin.
3. Backward waves can be measured in the femoral artery in rats.
4. The backward wave amplitude measured in the femoral artery in rats increases with
an increase in arterial stiffness.
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1.8 Research Objectives
The objectives are as follows:
1. Outline the theory behind wave separation analysis in a precise, rigorous manner.
2. Develop a peripheral artery technique for wave separation analysis in the rat.
3. Develop open source software to calculate dP/dtmin and the wave separation analysis
parameters.
4. Perform acute experiments to validate whether that dP/dtmin and backward wave am-
plitude are superior measures of arterial stiffness or not.
21
Chapter 2
Arterial Pressure dP/dtmin as a Novel Mea-
sure of Arterial Stiffness in a Rodent Model
of Vitamin D Excess
The following study will be submitted to the Journal of Pharmacological and Toxico-
logical Methods. Replication of some material from the introduction is unavoidable. This
manuscript describes a new measure of arterial stiffness, dP/dtmin, in the rat that is based
on analyzing the shape of the pressure wave; i.e., pulse waveform analysis. I contributed
90% of the manuscript. I developed the software, analyzed the data, prepared figures, and
drafted the manuscript. Lynn P. Weber and I designed the research study, interpreted re-
sults of experiments, and edited and revised the final version of this manuscript. Nagmeh
Z. Mirrhosseini and I performed the experiments and collated the data. This chapter also
contains a description of the software development process and verification in Section 2.2.6.
2.1 Introduction
Epidemiological studies have shown that arterial stiffness is associated with increased mor-
bidity and mortality in humans [53, 96]. Diseases caused by arterial stiffness include cardiac
failure [67], hypertension [53], small vessel disease of the kidney leading to renal failure, and
small vessel disease of the brain leading to dementia [82, 96]. Inflammation and aging causes
the artery to become stiff due to structural thickening and calcification [79, 92, 139]. Age-
related elastic structural protein damage transfers stress from elastin to collagen fibers that
have a higher elastic modulus contributing to stiffening of the arterial wall [7, 55]. Vitamin D
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excess has been shown to calcify rodent arteries [51, 58, 140], resulting in arterial stiffening.
Vitamin D deficiency has also been shown to stiffen arteries in humans [1]. Vitamin D defi-
ciency and excess versus normal vitamin D was used to provide a range of arterial stiffness
in rats in this study.
Blood pressure telemetry provides sensitive pulse waveform data from rodents in research
trials, which may be used to predict changes in arterial stiffness in humans. The shape of
the arterial pulse waveform changes with the elasticity of the artery because the effectiveness
of the vessel wall to dampen the pulsatile force of blood is altered (Fig. 2.1; adapted from
[92]). The maximum time derivative of blood pressure (dP/dtmax), i.e., the maximum rate of
increase of pressure of the pulse waveform has been extensively used as a measure of arterial
stiffness in this laboratory and others [4, 33, 34, 35]. In other studies, the minimum time
derivative of blood pressure (dP/dtmin), i.e., the maximum rate of decrease of pressure of
the pulse waveform has been used to indicate rate of left ventricular relaxation [74, 138].
dP/dtmin indicates left ventricular relaxation when measured in the aorta immediately distal
to the left ventricle [74, 138]. This study measures dP/dtmin farther from the heart (i.e., in
the iliac artery). In the iliac artery, dP/dtmin no longer measures ventricular relaxation, and
we hypothesize that it will be indicative of arterial stiffness.
The objective of this study is to determine whether dP/dtmin can detect acute changes in
the vascular wall as well as or better than dP/dtmax. To compare dP/dtmin and dP/dtmax,
rodent models of vitamin D excess and deficiency were used to create a range of arterial
stiffness. Arterial pressure was measured using a blood pressure telemetry catheter inserted
into the iliac artery in rats fed varying levels of vitamin D for four weeks. The effectiveness
of pulse waveform dP/dtmin versus dP/dtmax as indicators of arterial stiffness was evaluated
by correlating with carotid peak systolic velocity, CA PSV, of the same rats at baseline and
week four. CA PSV is a measure of stenosis of the carotid arteries and vitamin D excess
or deficiency causes arterial stiffening, a stenotic-like condition [1, 51, 36]. Therefore, CA
PSV can be used as an indicator of arterial stiffening in this study to compare dP/dtmin and
dP/dtmax values for validation. The ability of dP/dtmin to detect changes in the vascular wall
was then verified by measuring dP/dtmin and dP/dtmax following administration of vasoactive
drugs acetylcholine (Ach) and norepinephrine (NE).
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Figure 2.1: Theoretical pulse waveform in stiff (right side) versus elastic (left side)
arteries. The shape of the pulse waveform changes depending not only with differing
degrees of stiffness, but also on location within the vascular tree. Compare a typical
trace if the pressure catheter is placed in the ascending aorta (top traces) versus in the
abdominal aorta (bottom traces).
2.2 Methods
2.2.1 Animal Surgery and Care
This work was approved by the University of Saskatchewan Animal Research Ethics Board
and adhered to the Canadian Council on Animal Care guidelines for human use. Twenty male
Wistar rats (150-450g) for Experiment 1 and four Male Sprague-Dawley rats (300-360g) for
Experiment 2 were housed individually and provided food and water ad libitum. Rats were
allowed to acclimatize five days before surgical implantation of blood pressure telemetry de-
vices using the method of Gentner and Weber [33]. The Wistar rats were premedicated with
Buprenorphine (20 µg/kg s.c.; Reckitt Benckiser Healthcare Ltd., Hull, UK); the Sprague-
Dawley rats were premedicated with Buprenophrine (20 µg/kg i.m.; Schering-Plough, Hert-
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fordshire, UK) and Midazolam (0.2 mg/mL i.m.; Sandoz Canada, Inc., Boucherville, Que.).
Surgical anesthesia was induced with 5% isoflurane and 1 L/min of oxygen and maintained
at 0.5-2% isoflurane and 0.5 L/min of oxygen. Trivetrin (30 mg/kg s.c.; Schering Canada
Inc., Pointe-Claire, Qubec) was administered prior to starting surgery. A PA-C10 transmit-
ter (Data Sciences International, St. Paul, Minn.) was implanted in the femoral artery and
advanced to the iliac artery caudal to the iliac bifurcation, with the transmitter body placed
subcutaneously in the left flank. Post-operative support included replacement fluids (5-15
mL saline s.c. in a 24 hour period for two days following surgery), buprenorphine (20 µg/kg
s.c. every 12 hours up to 48 hours), thermal support for 1 hour, and Trivetrin (30 mg/kg s.c.
daily for six days). Rats were allowed to recover for seven days post-surgery before entering
the study.
2.2.2 Experiment 1: Chronic Vitamin D Experiment
After surgical recovery, blood pressure and cardiac ultrasound measurements were performed
in the untreated Wistar rats (150-450g) to record a baseline measurement and performed after
four weeks of feeding diets with varying levels of vitamin D. Rats were split into five groups
of n=4 where each group received a different vitamin D diet. The Vitamin D diets had
exact dosages of 1,25-dihydroxyvitamin D (0 IU/g, 0.4 IU/g, 6.7 IU/g, 20 IU/g, and 100
IU/g) in a nutritionally complete rat diet (Harlan Laboratories, Madison, WI). The dietary
levels of vitamin D were chosen to provide each rat with a vitamin D dose equivalent to the
human doses that correspond to deficiency, the recommended daily intake, the maximum
therapeutic dose, the lower toxic limit and the upper toxic limit, respectively. The 0.4 IU/g
recommended daily intake vitamin D diet served as the control group. The vitamin D diets
fed to the rats did not cause any physical signs of illness or distress (poor grooming, lack of
appetite, decreased appetite, and stereotypic behaviour) during the study. At the end of the
experiment, the rat body weights and food consumption did not differ among groups.
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2.2.3 Experiment 2: Vasoactive Drug Experiment
After recovery from surgical implantation of blood pressure telemetry devices, four Male
Sprague-Dawley rats (300-360g) were used in an acute drug injection experiment. Anesthesia
was induced with 5% isoflurane then maintained at 3% isoflurane to examine the effects on
dP/dtmin and dP/dtmax of bolus injections of vasoactive drugs: ACh and NE and a saline
vehicle. Arterial blood pressure was recorded while a saline vehicle (0.5 mL/kg), ACh (0.91
ng/kg), and then NE (0.02 mg/kg) were intravenously injected into the tail vein [33]. A five-
minute washout period after blood pressure had returned to pre-injection values was used
between injections.
2.2.4 Pulsed Wave Doppler Procedure
Pulsed wave Doppler ultrasound at the carotid artery was performed to obtain CA PSV
using a Vevo 660 high-frequency ultrasound (VisualSonics, Markham, ON) equipped with
B-mode and Doppler imaging. Each ultrasound procedure took less than 30 minutes for
each animal. Prior to the ultrasound experiments, rats were anesthetized with 5% isoflurane
and were maintained at 0.5-3% isoflurane (Abbott Laboratories, Saint-Laurent, QC). Once
anaesthetized, the animals were placed in dorsal recumbency on an electrocardiogram (ECG)
plate (VisualSonics, Markham, ON) with each paw covered with electrode cream (Signa
Crme, Parker Laboratories, Fairfield, NJ) and secured to ECG contacts with surgical tape
to monitor heart rate throughout the entire experiment. A heated platform maintained an
internal body temperature of 37 oC as measured by a rectal temperature probe throughout
the ultrasound procedure. To reduce ultrasound image artifacts, hair was removed by wiping
the chest area after five minutes of depilatory cream treatment (Nair, New York, NY). EcoGel
200 (Eco-Med Pharmaceuticals, ON) was then applied to the thorax for ultrasound. A RMV
710B scanhead was used to first locate the right carotid artery at the level of its bifurcation
in B-mode and then a pulsed wave Doppler trace was obtained. The CA PSV was calculated
from the average peak velocity of three representative peaks. The averaged CA PSV was
then used per rat in a weekly time-point in subsequent statistical analyses.
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2.2.5 Pulse Waveform Analysis
The blood pressure data were analyzed using in-house software written specifically for these
experiments (PWanalyze software). The PWanalyze software uses 6th order central differences
to calculate the derivatives for the measures dP/dtmin and dP/dtmax. This software has been
released for free and is available at http://sourceforge.net/projects/PWanalyze under the
GNU public license.
In the chronic vitamin D experiment, arterial blood pressure was recorded at baseline
and at week four. The arterial blood pressure recordings were from continuously sampling
blood pressure-telemetry data in conscious unrestrained rats for five minutes every hour for
24 hours. Each five minute reading every hour was analyzed to measure both dP/dtmin and
dP/dtmax. The values of dP/dtmin and dP/dtmax over the entire 24 hour period were then
used per rat in subsequent statistical analyses. Waveforms that were artifacts were excluded
from the data analysis. A waveform was considered an artifact if there was gap in the
sampling from the rat telemetry device during a pressure pulse. Those rats with pressure
waveforms that consisted of more than 15% artifacts in the total trace were excluded from the
study to prevent error from blood pressure telemetry transmitter failure. Rats from groups
0 IU/g and 20 IU/g were excluded due to transmitter failure. Eighteen rats were part of
the final sample size for this experiment. The remaining rats included three in the 0 IU/g
group, four in the 0.4 IU/g group, four in the 6.7 IU/g group, three in the 20 IU/g group,
and four in the 100 IU/g group. In the acute drug injection experiment, 30 second segments
before and after drug injections were analyzed. The pre-injection and post-injection values
of dP/dtmin and dP/dtmax over the 30 seconds were then used in statistical analysis.
2.2.6 Software Development
PWanalyze software was developed in Python 2.7, a high-level interpreted language [122].
Python is designed for development productivity and is supported by a large community of
software developers. PWanalyze used several widely distributed packages including Numerical
Python for ease of mathematical operations, matplotlib for graphing, and wxpython for a
graphical user interface [5, 47, 102]. PWanalyze software uses 6th order central differences
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to calculate the derivatives for the measures dP/dtmin and dP/dtmax. To verify that the
derivatives were correct, PWanalyze was tested with periodic functions with known analyti-
cal derivatives and varying domain discretizations.
The user of PWanalyze is able to specify a data file to be analyzed. A sample data file
showing the desired CSV format is provided with the software release. The data are displayed
graphically such that the user is able to navigate the blood pressure trace and select a portion
of the trace to be analyzed. PWanalyze then calculates dP/dtmin, dP/dtmax, systolic blood
pressure, diastolic blood pressure, pulse pressure, and heart rate. The results of the analysis
are displayed directly on the blood pressure trace as shown in Figure 2.3 and in text format
in an analysis log for further statistical analysis. Both the graphical blood pressure trace and
analysis log can be saved at any time in the analysis process by the user. PWanalyze is a
freely available tool for researchers using rats to investigate cardiovascular disease to calculate
traditional measures of arterial stiffness, dP/dtmax and the novel measure dP/dtmin.
2.2.7 Statistical Analysis
All measurements are reported as a median and range. In the chronic vitamin D exper-
iment, the effects of individual variation on the measurements were removed by using a
percent change from baseline to week four for each of the parameters prior to statistical anal-
ysis. Spearmans correlation and Bland-Altman analysis were used to compare dP/dtmin and
dP/dtmax to CA PSV [11]. All Spearmans correlations and Bland-Altman analyses were
performed using 36 independent measures in total, i.e., baseline and final measurement in 18
different rats. Correlations with r > 0.6 were considered to show a strong relationship. The
Bland-Altman analysis 95% limits of agreement was reported as a mean bias ± 2 standard
deviations. Comparisons between groups to measure treatment effects were calculated using
a Kruskal Wallis test followed by Mann-Whitney U-test corrected for multiple comparisons
by Bonferonni’s method. In the acute drug injection experiment, the effects of each drug were
investigated by using the difference between pre-injection and post-injection parameter val-
ues prior to statistical analysis. The Kruskal Wallis test followed by Mann-Whitney U-tests
corrected for multiple comparisons by Bonferonni’s method were used to compare treatment
effects. Statistics were performed using R [100]. Results with p < 0.05 were considered to
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be statistically significant.
2.3 Results
The values at baseline for systolic blood pressure, diastolic blood pressure, pulse pressure,
heart rate, and CA PSV in the chronic vitamin D experiment were 120 (105-305) mmHg, 91
(77-101) mmHg, 33 (14-39) mmHg, 363 (258-420) bpm and 646 (261-794) cm/s, respectively,
for all groups combined (n=18 rats). The change from baseline to the end of the experiment
for systolic blood pressure, diastolic blood pressure, pulse pressure, heart rate, and CA PSV
values for each treatment group is shown in Table 2.1. The measured CA PSV range (321-909
cm/s) indicated that arterial stiffness at the end of the experiment was sufficiently varied to
explore the comparability and potential superiority of dP/dtmin versus dP/dtmax as indicators
of arterial stiffness. Before exploring this comparison, we first examined more traditional
measures of arterial stiffness (CA PSV, systolic blood pressure, and pulse pressure). Systolic
blood pressure varied significantly between groups. Systolic blood pressure showed a trend
for increase in 0, 6.7 and 100 IU/g/day groups compared to control (normal diet) (Table 2.1).
However, it should be noted that systolic blood pressure increases in response to many factors
in addition to increased arterial stiffness, including increased cardiac output or increased
diastolic pressure, so it is not a reliable indicator of arterial stiffness. Diastolic pressure
varied significantly between groups with treatment. Diastolic blood pressure is not generally
considered to be reflective of arterial stiffness; however, there was a trend for increase at
the highest vitamin D dose group compared to control (Table 2.1). Pulse pressure was not
significantly different from control in any treatment group, indicating that this measure of
arterial stiffness was relatively insensitive. Heart rate is not an indicator of arterial stiffness,
but does confound interpretation of increases in systolic blood pressure, pulse pressure, and
CA PSV if it is significantly altered with treatment. Although there are trends for change,
heart rate was highly variable and showed no significant differences among treatment groups
(Table 2.1). Finally, the clinically important CA PSV showed a trend for increase in the 0,
6.7, and 100 IU/g/day groups compared to control, but was not significant (Table 2.1). The
pulsed wave Doppler trace of a rat in the 0 IU/g treatment group showed greater CA PSV
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Table 2.1: Traditional measures of arterial stiffness and blood pressure for each treat-
ment group reported as change from baseline at the end of the experiment, where pulse
pressure is denoted as PP, carotid peak systolic velocity is denoted as CA PSV, and
heart rate is denoted as HR. Values reported as median and range in parentheses. The
0.4 IU/g Vitamin D diet is the control.
Treatment ∆Systolic
Blood
Pressure
(mmHg)
∆Diastolic
Blood
Pressure
(mmHg)
∆PP
(mmHg)
∆CA PSV
(cm/s)
∆HR (bpm)
0 IU/g n=3 12 (6-14) 7 (3-9) 3 (-1-11) 89 (-148-281) -36 (-59- -4)
0.4 IU/g
control n=4
-1 (-5-4) 5 (2-17) -7 (-14- -4) -128 (-218-26) 6 (-41 - 42)
6.7 IU/g n=3 8 (8-9) 8 (5-10) 0 (3-4) 90 (-13-305) 16 (-11-50)
20 IU/g n=3 2 (2-6) 4 (3-5) 0 (-2-2) -7 (-69-54) -55 (-80- -54)
100 IU/g n=4 15 (8-25) 17 (12-21) -3 (-12-15) 125 (52-405) -26 (-53-53)
Note: The Kruskal-Wallis test was significant for a treatment differences in systolic blood pressure
(p = 0.009) and diastolic blood pressure (p = 0.041).
Table 2.2: PWanalyze calculated measures of arterial stiffness, dP/dtmax and
dP/dtmin for each treatment group at the end of experiment. Values reported as median
and range in parentheses. The 0.4 IU/g Vitamin D diet is the control.
Treatment dP/dtmax (mmHg/s) dP/dtmin (mmHg/s)
0 IU/g n=3 1678 (555-2148) -738 (-785- -290)
0.4 IU/g control n=4 1055 (808-2765) -481 (-883- -413)
6.7 IU/g n=3 2256 (1281-2710) -813 (-1020- -588)
20 IU/g n=3 2290 (2048-2534) -858 (-888 - -815)
100 IU/g n=4 1651 (1045-1944) -704 (-812- -501)
measured after four weeks compared to CA PSV measured before entry into the study; see
Figure 2.2. The increase in CA PSV indicates that arterial stiffening has occurred during
the trial because of the 0 IU/g vitamin D diet. Taken together, although these traditional
indicators of arterial stiffness showed the expected direction of change, the sensitivity for
detecting significant increases was not great, requiring highly toxic levels of vitamin D for
consistent detection, thereby illustrating the need for different, more sensitive methods of
arterial stiffness detection.
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Figure 2.2: Representative pulsed wave doppler traces from the carotid arteries of a
rat before entry into the experiment (top trace) versus after four weeks of no Vitamin
D (bottom trace) in the diet. The yellow arrows show where the CA PSV is measured
on the Doppler trace. The lower trace shows greater peaks in CA PSV compared to
the top trace, indicating that CA PSV has increased with lack of Vitamin D, indicating
arterial stiffening compared to the normal dietary level.
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Figure 2.3: Sample data output using PWanalyze designed specifically for this ex-
periment. The pulse waveform data was obtained from a rat with a telemetry blood
pressure catheter placed in the iliac artery. The top trace is a rat before entry into
the experiment and the bottom trace is the same rat after four weeks of no Vitamin D
in the diet. The symbols indicate the points in each pulse where each of the analysis
parameters were equal to the values calculated. The program then generates output
which takes averages of the values within a selected area and reports mean values for
each parameter.
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Figure 2.4: Correlation of carotid artery stiffness measured by carotid artery peak sys-
tolic velocity (CA PSV) with two different parameters calculated using custom-authored
software created for this study, dP/dtmax and dP/dtmin. Two-tailed Spearmans statis-
tics and p-values for the regression are shown. Data was expressed as a percent of the
baseline (pre-diet treatment) values for each individual rat in order to remove inter-
individual variation.
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Values for dP/dtmin and dP/dtmax were calculated using PWanalyze and are shown for
each treatment group at the end of the experiment in Table 2.2. Figure 2.3 shows two
representative pulse waveform traces analyzed by PWanalyze. The tracings in Figure 2.3
show that dP/dtmin and dP/dtmax increased in magnitude at the end of the study for a rat
in the 0 IU/g treatment group. The range of values for CA PSV was used to explore whether
dP/dtmin, and dP/dtmax indicate arterial stiffness. The change in pulse waveform analysis
parameters, dP/dtmin, and dP/dtmax, from baseline are both significantly correlated with
the change in CA PSV (Figure 2.4; r =0.616, -0.777, respectively; p < 0.01 for both). The
correlation is slightly stronger for dP/dtmin compared to dP/dtmax, which confirms that
dP/dtmin is at least as good as dP/dtmax in detecting simlar changes as CA PSV, but we
cannot say based on this analysis whether dP/dtmin is better or not despite the slightly higher
r-value. The change in dP/dtmin and dP/dtmax did not vary significantly between treatment
groups; see Table 2.2. Bland-Altman plots were generated as a second statistical method to
support conclusions from the correlation analyses and to further examine the relationship
between dP/dtmin, dP/dtmax, and CA PSV (Figure 2.5). The Bland-Altman plots showed
similar systemic bias of dP/dtmin (-19%) and dP/dtmax (-24%) to underestimate the change
arterial stiffness compared to CA PSV and low systemic bias when dP/dtmin was used to
estimate dP/dtmax (-5%). The limits of agreement between dP/dtmin and CA PSV were the
same as the limits of agreement between dP/dtmax and CA PSV (48%). This supports that
dP/dtmin and dP/dtmax equally estimate the change in CA PSV and that CA PSV changes
more than either dP/dtmin or dP/dtmax in response to arterial stiffness.
After developing the PWanalyze software using the chronic vitamin D dataset, we wanted
to confirm whether this software could perform under different conditions where changes in
arterial stiffness are expected. Specifically, we wanted to compare whether PWanalyze could
detect acute changes in rats induced by vasodilatory and vasoconstrictive drugs in normal
rats. Thus, this acute drug experiment was a separate data set used to confirm the results
with dP/dtmin and dP/dtmax. Table 2.3 shows the effect of a saline vehicle, ACh, and NE
on blood pressure, dP/dtmin, and dP/dtmax. The saline vehicle had no significant effect on
systolic, diastolic, or pulse pressures, as well as having no effect on heart rate, and dP/dtmax.
As expected, ACh caused a significant decrease in systolic blood pressure, diastolic blood
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Figure 2.5: Bland-Altman plots comparing dP/dtmax (-19 ± 48%) and dP/dtmin (-24
± 48%) to carotid artery stiffness measured by carotid artery peak systolic velocities
(CA PSV), and dP/dtmax to dP/dtmin (-5 ± 16%). Data were expressed as a percent
of the baseline (pre-diet treatment) values for each individual rat in order to remove
inter-individual variation.
pressure, and pulse pressure, but no effect on heart rate. After ACh administration, both
dP/dtmin and dP/dtmax significantly changed compared to the saline vehicle. The significant
negative change in dP/dtmax is indicative of decreasing slope in the rapid systolic rise in pres-
sure, consistent with decreased arterial stiffness. The positive change in dP/dtmin indicates a
less steep downward slope in the rapid diastolic decrease in pressure with each pulse, consis-
tent with decreased arterial stiffness. In contrast, NE administration significantly increased
systolic, diastolic, and pulse pressures, but also showed a significant decrease in heart rate.
The decrease in heart rate after NE confounds interpretation of arterial stiffness from systolic
and especially pulse pressures. However, a drop in heart rate would tend to decrease, not
increase pulse pressure, thus the observed increase in pulse pressure after NE administration
can confidently be attributed to increased arterial stiffness. Similarly, the large significant
positive change in dP/dtmax indicates a much steeper slope in the rapid systolic rise in pres-
sure with each pulse, consistent with increased arterial stiffness. While heart rate changes by
themselves can alter dP/dtmax, the observed decrease in heart rate would tend to reduce, not
increase slope. Since we observed a positive change, this indicates the significant dP/dtmax in-
crease is indicative of increased arterial stiffness. Finally, the dP/dtmin had a large negative
change after NE administration compared to pre-injection (negative ∆dP/dtmin), indicating
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Table 2.3: Effect of a saline vehicle (0.5 mL/kg) and vasoactive drugs acetylcholine
(ACh 0.91 ng/kg) and norepinephrine (NE 0.02 mg/kg) on blood pressure, dP/dtmax,
and dP/dtmin. Values reported as median and range in parentheses. The saline vehicle
is the control. Note: *, p < 0.05; **, p < 0.01 versus vehicle group in a posteriori
Mann-Whitney U-tests with Bonferonni correction after Kruskal Wallis test.
∆Systolic
Blood
Pressure
(mmHg)
∆Diastolic
Blood
Pressure
(mmHg)
∆PP
(mmHg)
∆HR (bpm) ∆dP/dtmax
(mmHg/s)
∆dP/dtmin
(mmHg/s)
Vehicle 0 -1 0 (0-1) -1 -2 2
n=4 (-3-6) (-3-6) (0-1) (-4-6) (-40-73) (-39-12)
ACh -16 -10 -5 3 -333 75
n=4 (-21- -12)* (-16- -7)* (-7- -4)* (2-6) (-398- -249)* (69-88)*
NE 66 41 25 -13 1012 -1209
n=4 (63-80)* (37-46)* (23-33)* (-14- -8)* (499-1394)* (-1645- -1037)*
a steeper negative slope in the rapid diastolic decrease in pressure with each pulse, consis-
tent with increased arterial stiffness. It is known that dP/dtmax can increase when there is
increased pulse pressure at a given heart rate [33]. Although dP/dtmin has not been previ-
ously used to measure arterial stiffness, changes in pulse pressure at a given heart rate could
possibly affect dP/dtmin. However, changes in pulse pressure and heart rate did not account
for all of the changes in dP/dtmin and dP/dtmax in this study. For example, in the 0 IU/g
group dP/dtmin decreased further than what was predicted from the change in pulse pressure
and heart rate and dP/dtmax increased further than what was predicted from the change in
pulse pressure and heart rate.
2.4 Discussion
The primary discovery of this study shows dP/dtmin to be an equally good indicator of arterial
stiffness in comparison to dP/dtmaxthrough comparison with acute and chronic changes in
arterial stiffness. The correlation and Bland-Altman comparison to CA PSV was similar
for dP/dtmin and dP/dtmax. NE administration caused dP/dtmin to decrease significantly
and dP/dtmax to increase significantly. ACh caused a negative change in dP/dtmin and
a positive change in dP/dtmax but was not significant. The changes seen with NE and
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ACh administration are consistent with the increase and decrease of arterial stiffness from
vasoconstriction and vasodilation, respectively.
In practice, blood pressure telemetry and cardiovascular research software packages are
necessary to calculate dP/dtmin and dP/dtmax. Many commercial software packages are able
to calculate dP/dtmax from arterial blood pressure traces; they are also able to calculate
dP/dtmin and dP/dtmax from pressure-volume loops in the heart. The PWanalyze software
written for this experiment is the only known software package that calculates dP/dtmin from
arterial blood pressure traces. Software support for dP/dtmin, dP/dtmax, systolic blood pres-
sure, diastolic blood pressure, and pulse pressure in PWanalyze increases the sensitivity of
detecting acute changes in the arterial wall. PWanalyze is beneficial in cardiovascular tox-
icology and pharmacology research for two reasons: (i) a high resolution rodent ultrasound
machine to measure CA PSV is not required to calculate dP/dtmin and dP/dtmax and (ii)
commercial software to calculate dP/dtmax is not needed. The resolution needed for rodent
cardiovascular ultrasound is higher than any clinical machine is capable of measuring and
the high resolution ultrasound needed is too expensive for all but the largest cardiovascular
research groups to afford. PWanalyze is designed to allow greater access for all cardiovas-
cular researchers with less expensive ultrasound machines. The commercial software that is
available to calculate dP/dtmax is very expensive, therefore, free open source software could
become an invaluable tool for researchers in this era of difficulty in obtaining research funds.
At the iliac artery, the dP/dtmin measured varied significantly between treatment groups,
whereas the dP/dtmax measured did not vary significantly between treatment groups. There-
fore, dP/dtmin should be examined in pulse waveform analyses. This new approach com-
plements the pre-existing use of dP/dtmax. Examining both dP/dtmin and dP/dtmax is ad-
vantageous because observing similar trends between dP/dtmin and dP/dtmax provides more
confidence in diagnosing arterial stiffness. A rodent telemetry system can be used to mea-
sure dP/dtmin and dP/dtmax to remove the cardiovascular depressant effect of anesthesia [33].
However, if a rodent telemetry system is not available, dP/dtmin and dP/dtmax can be mea-
sured under anesthesia in a terminal preparation with a heparinized fluid-filled catheter
manometer system or a Millar catheter.
The drawback of using dP/dtmin and dP/dtmax in rodents is that dP/dtmin and dP/dtmax are
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measured through invasive techniques requiring intravascular access. In humans, dP/dtmax has
been measured by pulse applanation tonometry in the radial artery; however, this technique
has not been reported in rats [4, 116]. To measure arterial stiffness in rats using dP/dtmin,
the pressure catheter must be placed near the iliac artery because dP/dtmin has not been
verified as a measure of arterial stiffness in other locations. For example, dP/dtmin might
not be a measure of arterial stiffness in the aortic arch due to the effects of left ventricular
relaxation [74, 138]. The relaxation of an artery (dP/dtmin) is a measure of the artery’s
stiffness. A stiff artery requires more force than an elastic artery when stretching to ac-
commodate blood. At the same heart rate, this means that the higher pressure required by
a stiffer artery will lead to a higher dP/dtmax value compared to a more compliant artery.
Conversely, the increased force used to stretch the stiff artery causes the artery to recoil faster
than the elastic artery leading to a decrease in dP/dtmin. Thus, the relaxation or elastic recoil
of the artery is measured by dP/dtmin when the catheter is inserted into the iliac artery. In
contrast, when the catheter is adjacent to the heart, dP/dtmin measures relaxation of the left
ventricle [74, 138]. The iliac artery is sufficiently distant from the heart that the pressure
difference from left ventricle relaxation is highly unlikely to affect dP/dtmin. Left ventricle
contraction is measured by dP/dtmax when the catheter is adjacent to the heart [74, 138].
Arterial stiffness is measured by dP/dtmax in the iliac artery and radial artery [4]. Future
work should address where dP/dtmin and dP/dtmax measure arterial stiffness in the arte-
rial tree. The iliac artery is an easily accessible area to measure arterial stiffness in rodent
cardiovascular studies. The iliac artery was used to obtain measures of arterial stiffness,
dP/dtmin and dP/dtmax, that were valuable in detecting both chronic and acute changes in
arterial stiffness.
Toxicology and pharmacology studies that measure intravascular blood pressure should
use the parameters dP/dtmin and dP/dtmax to detect changes in arterial stiffness. The dis-
covery of these new indicators of arterial stiffness increases the available measurements at the
disposal of researchers. Development of PWanalyze software further decreases financial and
technical barriers to cardiovascular researchers in obtaining valuable measurements of arte-
rial stiffness. Using PWanalyze software, dP/dtmin and dP/dtmax can be easily calculated to
increase the sensitivity of detecting acute changes in the vascular wall. With more accurate
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measurement of arterial stiffness in rodent models of cardiovascular disease, translational
cardiovascular studies will be better able to predict cardiovascular morbidity and mortality
associated with arterial stiffness in humans.
39
Chapter 3
Wave Separation Analysis
This chapter is dedicated to outlining the mathematical approach taken in the Chapter 4
for wave separation analysis and how to calculate backward waves in rat peripheral arteries.
Wave separation analysis has been applied to the ascending aorta in the rat [17, 24, 43,
60, 105]. To perform wave separation analysis in the ascending aorta, a thoracotomy is
performed so that a flow probe can be placed on the aorta. A pressure probe is then placed
into the ascending aorta by insertion through the carotid artery. To place the flow probe in
the ascending aorta, the rat must be endotracheally intubated and mechanically ventilated
before the chest is opened. Intubation and mechanical ventilation are technically difficult
to perform and affect the cardiopulmonary status of the rat. This thesis explores using
peripheral arteries for wave separation analysis to increase the feasibility of this technique
in more rodent cardiovascular studies. The advantage of using peripheral arteries for wave
separation analysis is that it less technically demanding for the researcher and surgically
invasive for the rodent. The objective of this chapter is to outline the mathematics behind a
novel technique for wave separation analysis in rat peripheral arteries in more detail than is
provided in Chapter 4.
3.1 Fourier Analysis
Fourier analysis was used in this thesis for wave separation analyses, and thus a brief dis-
cussion on the approach taken is needed here. Fourier analysis is a method of uniquely
respresenting a waveform as a series of sinusoidal functions also known as harmonic waves.
Representing the waveform as harmonic waves simplifies the study of blood pressure and
flow. To perform wave separation analysis, the pressure and flow traces are represented in
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the frequency domain using a Fourier series (Equations 3.1a and 3.1b; Appendix B).
P (t) =
k=∞∑
n=1
MP,n cos(nωt+ ϕP,n), (3.1a)
Q(t) =
k=∞∑
n=1
MQ,n cos(nωt+ ϕQ,n), (3.1b)
ω =
2pi
L
, (3.1c)
where t ∈ R (i.e., time is in the set of real numbers), P (t) is pressure measured in the artery,
Q(t) is flow measured in the artery, n is a harmonic number in the Fourier series, MP,n is
the modulus of the nth harmonic of pressure, MQ,n ∈ R is the modulus of the nth harmonic
of flow, ω is the angular frequency, L is the period of the cardiac cycle, ϕP,n is the phase
angle at the nth hamonic of pressure, and ϕQ,n is the phase angle at the nth harmonic of
flow. Additionally, k is the number of harmonics used and is usually truncated at 15 to 20
harmonics in this type of analysis [80, 88]. Each harmonic is expressed in phasor notation,
described in Appendix C.
The number of harmonics that can have physical meaning depends both on the sampling
rate and accuracy of the recording equipment. If there are N time-points recorded in the
pressure or flow measurement, N/2 harmonics can be meaningfully determined because each
harmonic has two variables, modulus and phase angle. In this experiment, the sampling rate
of 1000 samples per second limits the frequency that can be analyzed to 500 Hz. Because the
rat’s heart rate is generally less than 400 beats per a minute (6.7 Hz), there are a 150 data
points for each heart beat and therefore 75 harmonics can be significant. Aliasing occurs
when there are harmonics above N/2 that are are significant (have a non-trivial modulus).
The recording equipment uses a 160 Hz filter for blood flow and an 1 kHz filter for blood
pressure. Aliasing is technically possible with a 1kHz filter for blood pressure and a sampling
rate of 1000 samples per a second; however, physiologically, the pressure waveforms have
negligible power above 70Hz in the rat so significant aliasing is unlikely [80].
To compare with human wave separation analysis, generally ten harmonics (up to 30 Hz)
are calculated in humans and ten to fifteen harmonics (up to 100 Hz) have been calculated
previously in rats [88, 80]. To quantitatively determine the significant harmonic terms in the
arterial waveform, the total variance of the original measured wave values Vt (Equation 3.2)
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can be compared against the variance of the calculated Fourier series Vs (Equation 3.3) using
Parseval’s theorem [86]. Parseval’s theorem states that the variance of the original function
is equal to the variance of the Fourier series.
Vt =
1
m
m∑
t=1
P (t)2 −
(
1
m
m∑
t=1
P (t)
)2
, (3.2)
Vs =
1
2
k∑
n=1
M2P,n, (3.3)
where m is the number of ordinates and k is the number of harmonics. Often, Vs
Vt
exceeds
0.995 in seven or eight harmonics [88]. For the purposes of this thesis, the Fourier series
is considered sufficiently accurate when Vs
Vt
> 0.99. The Fourier series was found to be
sufficiently accurate in this thesis work at five harmonics and to exceed 99.5% accuracy at
thirteen harmonics in a preliminary experiment with twenty male Wistar Rats.
3.2 Impedance
In the arterial system, impedance is the ratio of oscillatory pressure to flow [88]. The concept
of impedance is borrowed from electrical engineering and is analagous to the ratio of voltage
to alternating current in a circuit. Impedance is based on Ohm’s law for alternating current;
that is, the relationship between current and voltage in a circuit is described by a complex
quantity called impedance. When the pressure and flow (analagous to voltage and current)
are steady, impedance is more commonly known as resistance. Two types of impedance,
input impedance Zin and characteristic impedance Zc, are calculated in wave separation
analysis [106, 133]; they are defined in the subsequent sections.
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3.2.1 Input Impedance
Input impedance (Zin) is defined as the ratio of oscillating pressure and oscillating flow at a
particular arterial site [88]. Input impedance is calculated by
Zin(t) =
k∑
n=1
MP,n cos(piωt+ ϕP,n)
MQ,n cos(piωt+ ϕQ,n)
, (3.4a)
MZin,n =
MP,n
MQ,n
, (3.4b)
ϕZin,n = ϕP,n − ϕQ,n, (3.4c)
Zin(t) =
k∑
n=1
MZin,n cos(piωt+ ϕZin,n), (3.4d)
where t ∈ R, n is a harmonic number, k is the total number of harmonics computed, MZin,n
is the modulus of the nth harmonic of input impedance, ω the angular frequency is defined
in Equation 3.1c, and ϕZin,n is the phase angle at the nth harmonic of impedance. Input
impedance includes both forward and backward travelling waves [133]. The presence of
backward travelling waves introduces a phase shift between the measured pressure and flow
waves. Input impedance is a complex number due to this phase shift (Equation 3.4d). Phasor
arithmetic is used to divide the Fourier harmonics of pressure and flow (Equation 3.4b and
3.4c). Phasor arithmetic is outlined in Appendix C.
3.2.2 Characteristic Impedance
Characteristic impedance (Zc) is the ratio between oscillatory pressure and flow in an artery,
when the waves are not influenced by wave reflection [88]; i.e., only forward travelling waves
are considered. Obtaining Zc from experimental data is not possible because there is no
circumstance where pressure and flow are not altered by wave reflection; however, Zc can
be estimated from Zin [88]. When estimating characteristic impedance, only the moduli of
the input impedance are considered. The phase is set to zero because there are no wave
reflections by definition of characteristic impedance. Therefore, characteristic impedance is a
real number because there is no phase shift. In the absence of wave reflections, the pressure
would travel in phase with the flow. There are many methods to estimate the characteristic
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impedance from the input impedance. Mitchell et al. [80] found the three most common
methods of calculating Zc to be equivalent in rats: Zc computed as the average of moduli of
Zin above and including the second harmonic, Zc computed as the average of all moduli after
and including the first input impedance moduli minimum, and Zc computed as the average
of all moduli after the first input impedance moduli minimum. For this experiment, Zc was
computed as the average of moduli of Zin above and including the second harmonic,
Zc =
1
k − 1
k∑
n=2
MZin,n, (3.5)
where Zc ∈ R is the characteristic impedance, MZin,n is the modulus of input impedance
at the nth harmonic and k is the maximum amount of harmonics calculated. In humans,
Zc average was calculated above 2 Hz (the second harmonic) [85]. In rats, the average has
been computed from the second to tenth harmonic [80]. In another human studies, Zc is the
average of the third to the tenth harmonic and of the fourth to the tenth harmonic [106, 135].
The Zc average was chosen to be from the second to the tenth harmonic for this thesis.
3.3 Backward Wave Separation
The forward and backward pressure waves can be calculated from the measured pressure
and flow waves once characteristic impedance is known. The Fourier series representing the
forward and backward pressure waves are calculated from the Fourier series of the measured
pressure and flow waves follows [135]:
Pf = ZcQf =
Pm + ZcQm
2
, (3.6)
Pb = −ZcQb = Pm − ZcQm
2
, (3.7)
where Equations 3.6 and 3.7 hold for each harmonic of the forward pressure wave Pf , forward
flow wave Qf , backward pressure wave Pb, backward flow wave Qb, measured pressure wave
Pm, and measured flow wave Qm.
Equations 3.6 and 3.7 can be expanded and simplified using phasor arithmetic outlined
in Appendix C:
Pf (t) =
1
2
k∑
n=1
[
MPm,n cos(piωt+ ϕPm,n) + ZcMQm,n cos(piωt+ ϕQm,n)
]
, (3.8)
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where t ∈ R, n is a harmonic number in the Fourier series, i is the imaginary unit, Pf (t) is
forward travelling pressure in the artery, Zc is the characteristic impedance of the artery, ω
the angular frequency is defined in Equation 3.1c, MPm,n is the modulus of the nth harmonic
of measured pressure, ϕPm,n is the phase angle at the nth harmonic of measured pressure,
MQm,n is the modulus of the nth harmonic of measured flow, and ϕQm,n is the phase angle
at the nth harmonic of measured flow.
The addition of the harmonic cosine functions are then represented using complex numbers
in rectangular form for each harmonic n:
aP,n = MPm,n cos(ϕPm,n),
aQ,n = ZcMQm,n cos(ϕQm,n),
bP,n = MPm,n sin(ϕPm,n),
bQ,n = ZcMQm,n sin(ϕQm,n),
an = aP,n + aQ,n,
bn = bP,n + bQ,n.
The rectangular form is converted back into a harmonic cosine function of the forward pres-
sure wave:
Mn =
√
a2n + b
2
n,
ϕn = arctan(
bn
an
),
Pf (t) =
1
2
k∑
n=1
[Mn cos(piωt+ ϕn)].
The subtraction of harmonic cosine functions is also represented using complex numbers in
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rectangular form for calculation of the backward pressure wave:
Pb(t) =
1
2
k∑
n=1
[
MPm,n cos(piωt+ ϕPm,n)− ZcMQm,n cos(piωt+ ϕQm,n)
]
, (3.9)
aP,n = MPm,n cos(ϕPm,n), (3.10)
aQ,n = ZcMQm,n cos(ϕQm,n), (3.11)
bP,n = MPm,n sin(ϕPm,n), (3.12)
bQ,n = ZcMQm,n sin(ϕQm,n), (3.13)
an = aP,n + aQ,n,
bn = bP,n + bQ,n,
Mn =
√
a2n + b
2
n,
ϕn = arctan(
bn
an
),
Pb(t) =
1
2
k∑
n=1
[Mn cos(piωt+ ϕn)],
where Pb(t) is backward travelling pressure in the artery.
3.4 Wave Separation Analysis Parameters
After performing wave separation analysis, reflection index, characteristic impedance, am-
plitude of the forward pressure wave, and amplitude of the backward pressure wave can be
calculated as potential measures of arterial stiffness.
The reflection index RI represents the ratio of the backward wave to the measured wave
and is calculated by:
RI =
Ab
Af + Ab
where Ab is the amplitude of the backward travelling pressure wave Pb(t), and Af is the
amplitude of the forward travelling pressure wave Pf (t).
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3.5 Assumptions in Wave Separation Analysis
Wave separation analysis assumes that the arterial system can be treated as a simple linear
model [29, 88]. In practice, each individual harmonic term of pressure is related only to the
corresponding harmonic term of flow [88]. The effect of interaction, introduced by current
blood pressure and flow measurement techniques, between harmonic terms is small, less than
one percent, and can therefore be neglected [29, 88].
3.6 Software Development
The WSanalyze software package was developed using Python 2.7, a high-level interpreted
language that is commonly used in many scientific communities [122]. WSanalyze uses several
widely distributed packages including Numerical Python for ease of mathematical operations,
OpenGL for display of data and results, and GLUT for a simple window interface [5, 56, 109].
The purpose of developing software was to provide researchers without any programming
ability a tool to perform wave separation analysis in rats. The user of WSanalyze is able to
specify a data file to be analyzed. The data are displayed graphically, and the user can view
the blood pressure and blood flow at any time point in the data file. The desired time points
to be analyzed can then be selected by the user. The results of wave separation analysis are
displayed graphically and are output as a text file for use in further statistical analysis.
When a data file is read by WSanalyze, the flow and pressure data are aligned for any
phase shift errors introduced by catheter and flow probe placement. The maximum first
derivative of the upstroke of the pressure and flow tracings are used to align the pressure and
flow data. The aligned data are then displayed to the user. Then once the user selects an
area of the data to be analyzed, a peak detection algorithm is used to detect the pulses to be
analyzed. Analysis involves first converting the pressure and flow tracing for each pulse into a
Fourier series by the method in Appendix B. Simpson’s rule is used for numerical integration
when calculating the coefficients of the Fourier series in Equations B.2, B.3, and B.4. Input
impedance is then calculated by Equation 3.4a and is used in the calculation of characteristic
impedance by Equation 3.5. Once characteristic impedance is known, the pressure wave can
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be separated into forward and backward waves by Equations 3.8 and 3.9. Wave separation
analysis parameters, reflection index, characteristic impedance, amplitude of the forward
pressure wave, and amplitude of the backward pressure wave are then calculated for each
pulse in the selection to be analyzed. The wave separation analysis parameters reported by
WSanalyze are an average of the values calculated for the selection of pulses specified by the
user.
To verify that the Fourier series calculations were correct, test data based on known
functions were generated then visual inspection of the Fourier transform and comparison of
variance between the Fourier series and original function were performed. The wave separa-
tion analysis algorithm was confirmed by inputting pressure and flow tracings from a canine
ascending aorta and comparing the results to those of Westerhof et al. [133]. Figure 3.1 shows
the similarity between the forward and backward pressure waves calculated by WSanalyze
and the forward and backward waves calculated by Westerhof et al. [133]. Verifying the
WSanalyze software against a known reference solution, the data of Westerhof et al., is a
necessary step to confirm program correctness prior to using the wave separation analysis
algorithm against experimental data. Chapter 4 presents the next step for validation, two
separate groups of rats were used to test the WSanalyze software. The first group was used
to develop the surgical data collection technique and confirm that WSanalyze software can
be used on rat pulse waveforms. The second group of normal Wistar rats was subjected to
acute vasoactive drug injections to confirm that the wave separation analysis parameters are
meaningful measures of arterial stiffness in rats.
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Figure 3.1: Validating WSanalyze software against a known data set. Canine ascend-
ing aorta pressure (Westerhof Original) and flow (not shown) tracings from Westerhof
et al. were used to are a dataset to test the WSanalyze software [133]. The waves
presented in the above figure are not on the same vertical scale. Generally, the back-
ward wave is smaller than the corresponding forward wave. The original forward and
backward pressure waves (top row) presented in the landmark paper of Westerhof et
al. are matched by the calculated forward and backward pressure waves (bottom row)
from WSanalyze. The reconstructed measured pressure wave (bottom row) is from the
sum of the calculated forward and backward pressure waves.
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Chapter 4
Wave Separation Analysis in Blood Pressure
Measured at the Femoral Artery of Rats
4.1 Preamble
The following study will be submitted to the Journal of Pharmacological and Toxicological
Methods. Replication of some material from the introduction is unavoidable. This chapter
describes a new technique of applying wave separation analysis to the femoral artery to detect
acute changes in the stiffness of the rat arterial wall. I contributed 90% of the manuscript.
I developed the software, performed the experiments, analyzed the data, prepared figures,
and drafted the manuscript. Lynn P. Weber and I designed the research study, interpreted
results of experiments, and edited and revised the final version of this manuscript.
4.2 Introduction
Arterial hypertension measured using indirect (cuff) techniques at the brachial artery has
long been known to be a major cardiovascular risk factor in humans [8]. However, end-organ
damage is also more closely related to central arterial blood pressure than brachial arterial
blood pressure; hypertension management is more effective when based on central arterial
blood pressure than peripheral arterial pressure [108]. In addition to the difficulty measuring
central pressure directly, a major issue is that brachial arterial blood pressure varies widely
from central arterial blood pressure due to the pulse pressure amplification phenomenon [70].
The pulse pressure amplification phenomenon can be explained by wave reflections [93].
A pressure wave is generated for each heart beat that travels down the artery called the
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incident or forward pressure wave. When the forward pressure wave reaches a branching or
narrowing in the artery, a portion of the wave is reflected back and is then called a backward
pressure wave. The backward wave reaches peripheral arteries, such as the brachial artery,
earlier than the central arteries. Therefore the peripheral backward pressure wave sums
with the forward pressure wave in systole rather than diastole leading to the pulse pressure
amplification. The relationship between the forward pressure wave and the backward pressure
wave has been shown to be a better indicator of arterial stiffness than brachial cuff blood
pressure [130]. An increase in the amplitude of backward pressure waves has been found to
be a consistent predictor of cardiovascular mortality independent of brachial arterial blood
pressure [129, 130]. Recent consensus has found that wave reflections and central arterial
hemodynamics are an early and sensitive predictor of cardiovascular morbidity and mortality
and can be used to guide pharmacological therapy [127].
The rat is an important model for cardiovascular disease and pharmacological develop-
ment. Wave reflections have been assessed in rats for varying pathophysiological states such
as aging, left ventricular hypertrophy, hypertension, calcification of arteries, chronic renal
failure, and diabetes [18, 16, 20, 24, 105]. Wave separation analysis in rats has been based
on ascending aorta pressure and flow measurements [16, 24, 43, 60, 105]. To measure flow in
the aorta, a thoracotomy needs to be performed. The rat must then undergo endo-tracheal
intubation and mechanical ventilation once the chest cavity is opened. However, mechanical
ventilation effects the cardiopulmonary status of the rat and requires specialized equipment
and training, thereby limiting the physiological relevance and wide applicability of this ap-
proach. The goal of this study is to explore novel approaches for wave separation analysis
that do not require a thoracotomy and mechanical ventilation, allowing for more physiolog-
ical measurements and greater potential for a wider number of researchers to use these less
invasive techniques.
Traditional measurements of arterial stiffness other than systolic blood pressure and pulse
pressure include carotid peak systolic velocity (CA PSV), pulse wave velocity, and transit-
time of the arterial pulse (TT). CA PSV is commonly used to indicate carotid artery steno-
sis [36]. CA PSV is also used as an indicator of arterial stiffness because arterial stiffening
causes a stenotic-like condition. Transit-time can be used to as an estimate of pulse wave
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velocity. Pulse wave velocity is a standard arterial stiffness measurement in humans and has
been shown to precede hypertension and structural changes to the arterial wall in rats [70, 41].
Transit-time can be measured non-invasively at the same time as CA PSV; this is an advan-
tage over only measuring pulse wave velocity in this experiment.
This study aims to present a method of wave separation analysis in a peripheral artery
where characteristic impedance, backward wave amplitude, and reflection index characterize
the arterial system of a rat. Two sites were examined for suitability and ease of use for
peripheral wave separation analysis: the femoral artery and the carotid artery. After an
initial exploratory experiment, the femoral artery was selected for further evaluation using
acutely administered drugs to induce vasodilation and vasoconstriction to test how well the
wave separation analysis software performed. Wave separation analysis parameters were
compared with traditional indicators of arterial stiffness: blood pressure, CA PSV, and TT.
The goal was to validate that backward waves could be measured at a peripheral artery in
the rat and prove that wave separation analysis parameters measured arterial stiffness in the
peripheral arterial system of rats. Backward wave amplitude was found to be a sensitive
indicator of arterial stiffness suitable for detecting acute changes to the vasculature.
4.3 Methods
4.3.1 Study Animals and Care
This work was approved by the University of Saskatchewan Animal Research Ethics Board
and adhered to the Canadian Council on Animal Care guidelines for human use. Eleven
male Wistar rats ranging in weight from 425 to 594 grams were used in Experiment 1 for
development of the surgical model and analysis software. Ten male Wistar rats ranging in
weight from 404 to 505 grams were used in Experiment 2 for an acute vasoactive drug injection
experiment. All rats were provided food and water ad libitum. The rats in Experiment 1
were housed in groups of two or three and the rats in Experiment 2 were housed individually.
All rats were allowed to acclimatize two weeks before the start of the experiment. All rats
were euthanized with Pentobarbital sodium (20 mL per 45 kg i.v.; Euthanyl; Bimeda-MTC
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Inc., Cambridge, ON, Canada) while anesthetized after the experiment concluded.
4.3.2 Experiment 1: Model Development
Carotid and femoral blood pressure and blood flow measurements were performed in a ter-
minal hemodynamic measurement procedure in eleven Wistar rats (425 to 594 grams) to
develop a technique of applying wave separation analysis in the peripheral arteries. Calibra-
tion of the pressure transducer 1.4 Fr. Millar Catheter (ADInstruments, Colarado Springs,
CO, USA) were performed with a mercury manometer, prior to the start of each experiment.
Atmospheric zeros were recorded prior to insertion of the probe. Calibration of Labchart 8
(ADInstruments, Colarado Springs, CO, USA) to record flow data was confirmed against the
TS420 Perivascular Flow Module (ADInstruments, Colarado Springs, CO, USA). The trans-
ducer and flow probe were kept in a saline bath prior to insertion. Rats were premedicated
with Hydromorphone (20 microg/kg s.c.; Sandoz Canada Inc., Qc, Canada), then surgical
anesthesia was induced with 5% isoflurane and 1 L/min of oxygen and maintained at 2%
isoflurane and 0.5 L/min of oxygen. The left and right femoral arteries were dissected away
from the femoral vein and nerve. A loose ligature using 5-0 braided silk suture was applied
proximally on the left femoral artery to control blood flow during pressure catheter place-
ment (Fine Science Tools Inc., BC, Canada). A tight ligature using 5-0 braided silk suture
was placed distally to the catheter introduction site to increase the lumen size of the artery
prior to insertion of the pressure catheter. A 22 guage one inch needle with the bevel bent
backwards at a 45 degree angle (BD Insyte; Abbott Laboratories, North Chicago, IL, USA)
was used to puncture the left femoral artery to introduce a 1.4Fr Millar Catheter (ADIn-
struments, Colarado Springs, CO, USA) that was then advanced three-quarters of an inch
proximally. The loose ligature was then tightened and secured around the Millar catheter.
A Transonics 1.5 PS flow probe was placed around the right femoral artery (ADInstruments,
Colarado Springs, CO, USA). ECG was recorded continuously throughout the experiment.
Blood pressure, blood flow, and the ECG were recorded continuously at a rate of 1000 sam-
ples per a second throughout the experiment using Labchart 8. Flow was recorded with a
150 Hz filter setting. In the rats used in the model development experiment, a fifteen minute
recording was taken of femoral artery blood pressure and blood flow. Then the right and left
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carotid arteries were isolated. The Millar catheter was placed into the right carotid artery
using the same ligature technique as the femoral artery and a 22 guage one inch needle as
a catheter introducer. Flow was measured with the Transonics flow probe placed on the
left carotid artery. Measurements for wave separation analysis were taken ten minutes after
instrumentation to allow the artery to relax after surgical manipulation. The location of
measurements taken in the rats used for model development is shown in Figure 4.1.
4.3.3 Experiment 2: Vasoactive Drug Injection
The ten Wistar rats (404-505 grams) were subjected to a pulsed wave Doppler procedure,
rested for seven days, and then hemodynamic measurements were performed in a terminal
hemodynamic measurement procedure. During the pulsed wave Doppler procedure, a 25
gauge three-quarter inch butterfly catheter was successfully placed in the tail vein in four of
the rats (Terumo Corporation, Tokyo, Japan). Saline (1 mL/kg) was injected intravenously
through the tail vein catheter. Norepinephrine (0.02 mg/kg; [101]) was injected, followed
by Sodium Nitroprusside (0.05 mg/kg; [120]). Between each injection, a washout period
of five minutes was observed. Pulsed wave Doppler velocity was measured 30 seconds af-
ter each bolus drug injection which corresponded to the average time when blood pressure
changed in preliminary experiments. Femoral blood pressure and flow were recorded in a
terminal hemodynamic measurement procedure as described for Experiment 1 and shown in
Figure 4.1. During the hemodynamic measurement procedure, a 26 gauge three-quarter inch
over-the-needle catheter (BD Insyte; Abbott Laboratories, North Chicago, IL, USA) was
placed in left femoral vein for bolus drug injections. The vasoactive drug experiment began
ten minutes after instrumentation to allow the arteries to relax after surgical manipulation.
The rats were subjected to the same bolus drug regime with saline, norepinephrine, and
sodium nitroprusside injected intravenously with five minutes washout between injections.
Ten waveforms, representing one respiration cycle, taken 30 seconds after each bolus drug
injection were used for wave separation analysis and blood pressure.
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4.3.4 Pulsed wave Doppler procedure
Pulsed wave Doppler ultrasound at the carotid artery was performed to obtain CA PSV, using
a Vevo 3100 high frequency ultrasound (FujiFilm VisualSonics Inc., Toronto, ON, Canada).
Each ultrasound procedure took no longer than 30 minutes for each animal. Prior to the
ultrasound experiments, rats were premedicated with Hydromorphone (20 microg/kg s.c.;
Sandoz Canada Inc., Qc, Canada), then surgical anesthesia was induced with 5% isoflurane
and 1 L/min of oxygen and maintained at 2% isoflurane and 0.5 L/min of oxygen (Abbott
Laboratories, Saint-Laurent, QC). Once anaesthetized, the rats were placed ventral side up
on an electrocardiogram (ECG) plate (FujiFilm VisualSonics Inc., Toronto, ON, Canada)
with each paw covered with electrode cream (Signa Crme, Parker Laboratories, Fairfield,
NJ) and secured to ECG contacts with surgical tape to monitor HR throughout the entire
experiment. A heated platform controlled by a temperature probe was inserted rectally to
maintain internal body temperature at 37oC. In order to prevent ultrasound artifacts, hair
was removed by depilatory cream treatment (Nair, New York, NY, USA) application for two
minutes, followed by physical removal with firm wiping with a series of dry tissues. EcoGel
200 (Eco-Med Pharmaceuticals, ON, Canada) was then applied to the thorax for ultrasound.
A MX400 scanhead (FujiFilm VisualSonics Inc., Toronto, ON, Canada) was used to first
locate the right carotid artery at the level of its bifurcation in B-mode and then pulsed
wave Doppler traces were obtained 30 seconds after each injection of saline, norepinephrine
and sodium nitroprusside. The CA PSV was calculated from the average peak velocity of 3
peaks. The transit-time (TT) between ventricular contraction denoted by the ECG-R wave
and doppler upstroke was also calculated for 3 peaks. The averaged CA PSV and TT was
then used per rat per injection in subsequent statistical analyses.
4.3.5 Wave Separation Analysis
The blood pressure data and blood flow data were analyzed using custom software written
specifically for these experiments (WSanalyze software). For each calculation, the first ten
consecutive cardiac cycles representing one respiratory cycle was selected for analysis. The
pressure and flow waveforms were programmatically aligned to correct any spatial time delay
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and filter-induced delay. The foot of the pressure waveform was aligned to the flow waveform
by the first maximum derivative during systole [80]. The pressure and flow waves were
represented as Fourier series as follows:
P (t) =
k∑
n=1
MP,n cos(nωt+ ϕQ,n),
Q(t) =
k∑
n=1
MQ,n cos(nωt+ ϕQ,n),
ω =
2pi
L
,
where t ∈ R, P (t) is pressure measured in the artery, Q(t) is flow measured in the artery,
n is a harmonic number in the Fourier series, MP,n is the modulus of the nth harmonic of
pressure, MQ,n ∈ R is the modulus of the nth of flow, ω is the angular frequency, L is the
period of the cardiac cycle, ϕP,n is the phase angle at the nth harmonic of pressure, and ϕQ,n
is the phase angle at the nth harmonic of flow. Coefficients of the Fourier series of pressure
and flow were calculated for the mean term through the 20th harmonic. The 2nd to the 10th
harmonic were used in characteristic impedance calculation, whereas all 20 harmonics were
used for calculations of forward and backward travelling waves. Arterial input resistance,
the steady-flow term of the impedance spectrum, is calculated as mean pressure divided by
mean flow. The arterial input impedance moduli are calculated for all 20 harmonics by
dividing the pressure modulus by the flow modulus at each harmonic. The arterial input
impedance phase for each harmonic is obtained by subtraction of flow phase by pressure
phase for all 20 harmonics. The characteristic impedance, Zc, was calculated by averaging
all input impedance moduli from the 2nd to 10th harmonic. The characteristic impedance
was then used to calculate the forward and backward waves by:
Pf (t) =
1
2
k∑
n=1
[
MPm,n cos(piωx+ ϕPm,n) + ZcMQm,n cos(piωx+ ϕQm,n)
]
Pb(t) =
1
2
k∑
n=1
[
MPm,n cos(piωx+ ϕPm,n)− ZcMQm,n cos(piωx+ ϕQm,n)
]
where Pf (t) is forward travelling pressure in the artery, Pb(t) is backward traveling pressure
in the artery, Zc is the characteristic impedance of the artery, MPm,n is the modulus of the
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nth harmonic of measured pressure, ϕPm,n is the phase angle at the nth harmonic of mea-
sured pressure, MQm,n is the modulus of the nth harmonic of measured flow, and ϕQm,n is
the phase angle at the nth harmonic of measured flow [135]. The systolic pressure, diastolic
pressure, pulse pressure, forward pressure wave amplitude, backward pressure wave ampli-
tudes, reflection index, and characteristic impedance were calculated for each cardiac cycle
separately then the final values were averaged for each of the cycles analyzed and were then
used per rat per injection treatment in subsequent statistical analysis.
4.3.6 Statistical Analysis
All baseline measurements are reported as a mean and standard error of all rats in the ex-
periment. Data were tested with a Shapiro Wilk test for normal distribution. Comparison
between femoral and carotid values (n = 11) for systolic pressure, diastolic pressure, pulse
pressure, forward pressure wave amplitude, backward pressure wave amplitudes, reflection
index, characteristic impedance, and CA PSV were performed with paired t-tests. Compar-
isons between treatments to measure vasoactive drug effects were calculated using a one-way
ANOVA with repeated measures (n = 10). One-way ANOVA was followed by Dunnett’s
a posteriori tests to compare treatment effects, the saline treatment served as a control.
Statistics were performed using SPSS Statistics Version 20 (IBM Canada Ltd., Markham,
ON, Canada). Results with p < 0.05 (two-tailed) were considered to be statistically signifi-
cant.
4.3.7 Peripheral Artery Site Selection
The femoral artery was chosen for further analysis in the acute vasoactive drug injection
experiment because of ease of surgical manipulation and access to the femoral vein for drug
injection. Complications in separate preliminary experiments included destruction of the
artery during catheterization, catheter sliding out of the artery due to improper fastening,
and hemorrhage. To avoid these complications, a small suture guage, such as 5-0 silk su-
ture is recommended for fastening the arterial pressure catheter. Irregular breathing was
observed after surgical instrumentation at the carotid artery in two rats due to phrenic nerve
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stimulation. Using the femoral artery avoids complications associated with phrenic nerve
stimulation. Characteristic impedance varied significantly between the carotid and femoral
arteries (1000 ± 90 dynes sec cm−5, 2940 ± 410 dynes sec cm−5, respectively). It is important
to note that impedance is site dependent; these reported values can be used as a reference
point for future studies where impedance is measured in the carotid and femoral arteries of
rats. Systolic blood pressure, diastolic blood pressure, pulse pressure, amplitude of the for-
ward wave, amplitude of the backward wave, and reflection index did not vary significantly
between the carotid and femoral arteries. Therefore, both the carotid and the femoral artery
are suitable sites for a wave separation analysis study. The femoral artery was used for the
acute vasoactive drug injection wave separation analysis study because of decreased surgical
complications and ease of manipulation of the artery.
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Figure 4.1: Diagram of arterial measurement sites for wave separation analysis. Dur-
ing model development in Experiment 1 the blood pressure was measured in the left
femoral artery (3) and the blood flow was measured in the right femoral artery (4) si-
multaneously for 15 minutes. Then the blood pressure was measured in the left carotid
artery (1) and the blood flow was measured in the right carotid artery (2) simultane-
ously for 15 minutes. During Experiment 2, the acute vasoactive drug experiment, bolus
drug injections began five minutes after commencing blood pressure measurements in
the left femoral artery (3) and blood flow measurements in the right femoral artery (4).
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4.4 Results
The characteristic impedance of the femoral artery prior to the acute drug injections was
3770 ± 860 (dynes sec cm−5). Figure 4.2 shows the separated forward and backward waves
after acute vasoactive drug injection in the same rat. There is an increased backward wave
after treatment with norepinephrine and a decreased backward wave after treatment with
sodium nitroprusside. From these representative waves, it was then possible to calculate
characteristic impedance, reflection index, and magnitude of forward and backward waves.
More importantly, it is evident that we were successful in separating forward and backward
waves with a noticeable difference in amplitude of the backward wave after injection of
vasoactive drugs. However, quantitative assessment of all data from all rats needed to be
examined next to determine whether these measures were sufficiently sensitive to detect the
changes.
Table 4.1 shows the effect of a saline vehicle, norepinephrine, and sodium nitroprusside
on reflection index, characteristic impedance, CA PSV, and heart rate. The wave separation
analysis parameters reflection index and characteristic impedance did not vary significantly
with vasoactive drug injection, indicating that with a sample size of ten rats, they are not
reliable indicators of arterial stiffness. However, reflection index responded as expected,
increasing when the artery is stiffened with norepinephrine injection and decreasing when
the artery is dilated with sodium nitroprusside injection. Characteristic impedance did not
respond as expected to acute vasoactive drug injections characteristic impedance decreased in
response to both norepinephrine and sodium nitroprusside injection. The clinically important
measure of arterial stiffness CA PSV showed a trend to decrease with norepinephrine injection
and increase with sodium nitroprusside injection, but it was not significantly different from
saline control. CA PSV should increase as artery is constricted with norepinephrine and
decrease as the artery is widened with sodium nitroprusside [99]. This is the opposite of
what was found, possibly because of the mechanisms through which the carotid artery acutely
regulates blood flow to the brain or due to the low sample size of four rats during the pulsed
waveform ultrasound procedure. CA PSV is not a reliable indicator of arterial stiffness
with acute vasoactive drug administration and low sample size in this experiment. Heart
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rate varied only slightly with treatment and was not significant and therefore, heart rate’s
confounding effect on interpretation of CA PSV, systolic blood pressure, diastolic blood
pressure, and pulse pressure can be ignored.
Figure 4.3 shows the significant effects of a saline vehicle, norepinephrine, and sodium
nitroprusside on traditional blood pressure measures systolic blood pressure, diastolic blood
pressure, and pulse pressure, and the WSA parameter amplitude of the backward wave. As
expected, norepinephrine injection caused a significant increase in traditional blood pres-
sure parameters systolic blood pressure, diastolic blood pressure, and pulse pressure. The
increase in these parameters can be attributed to an increase in arterial stiffness after nore-
pinephrine administration. Additionally, sodium nitroprusside caused a significant decrease
in traditional blood pressure parameters systolic blood pressure, diastolic blood pressure,
and pulse pressure. The decrease in these parameters could be attributed to a decrease in
arterial stiffness and vasodilation of the capillary beds as seen by the decreased backward
wave seen qualitatively in Figure 4.2. The wave separation analysis parameter, amplitude of
the backward wave, increased significantly with norepinephrine stiffening of the artery and
remained relatively unchanged with sodium nitroprusside injection. This indicates that the
amplitude of the backward wave can detect arterial stiffening due to norepinephrine at a
sample size of ten rats. With sodium nitroprusside injection, the vasodilation secondary to
isoflurane anesthesia may be interfering with the effect of sodium nitroprusside at the femoral
artery [59]. The amplitude of the backward wave was the most sensitive at detecting change
from wave separation analysis parameters measured at the femoral artery in rats.
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Figure 4.2: Pressure pulse waveform measured in the left femoral artery after intra-
venous injection of norepinephrine (0.02 mg/kg; top), and sodium nitroprusside (0.05
mg/kg; bottom) in the same rat. Pm is the measured pressure wave, Pf is the forward
pressure wave, and Pb is the backward pressure wave. The shape of the pulse waveform
and the size of the backward pressure wave changes with differing degrees of stiffness.
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Figure 4.3: Effect of vasoactive drugs norepinephrine (0.02 mg/kg) and sodium nitro-
prusside (0.05 mg/kg) versus saline vehicle on systolic blood pressure, diastolic blood
pressure, pulse pressure, and amplitude of the backward wave, in 10 healthy anes-
thetized rats. Note: *, p < 0.05 versus control (Saline) treatment in Dunnett’s a
posteriori test after one-way ANOVA with repeated measures.
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Table 4.1: Effect of vasoactive drugs norepinephrine (0.02 mg/kg) and sodium nitro-
prusside (0.05 mg/kg) versus saline vehicle on reflection index, characteristic impedance,
CA PSV, and heart rate. Values expressed as mean and standard error. Note: *, p <
0.05 versus control (Saline) group in Dunnett’s a posteriori test after one-way ANOVA
with repeated measures.
Treatment
Saline Norepinephrine Sodium Ni-
troprusside
Reflection Index (%) n=10 25 ± 3 30 ± 3 23 ± 2
Characteristic Impedance
(Zc) (dynes sec cm
−5) n=10
3481 ± 761 2573 ± 401 2580 ± 1280
CA PSV ( mm
sec
) n=4 592 ± 182 337 ± 64 702 ± 143
TT (millisec) n=4 20 ± 1 16 ± 2* 15 ± 1*
Heart Rate (beats
min
) n=10 374 ± 9 358 ± 12 374 ± 11
4.5 Discussion
The primary discovery of this study was that wave reflections are present and can be math-
ematically separated for quantification in the femoral artery in rats after acute vasoactive
drug injections. A backward wave could be manipulated by vasoactive drug administration
that was seen qualitatively on the pressure pulse waveform and measured quantitatively by
wave separation analysis. The novel peripheral artery wave separation analysis technique and
WSanalyze software provide a valuable and sensitive indicator of measuring arterial stiffness,
by means of the amplitude of the backward wave in the femoral artery.
Traditionally, systolic blood pressure and pulse pressure measured through the brachial
artery cuff oscillimetry is used as a cardiovascular indicator for arterial stiffness and a pre-
dictor of cardiovascular mortality [108]. Brachial artery cuff oscillimetry blood pressure
overestimates cardiovascular disease because amplification of the pressure pulse occurs in the
periphery [108]. Brachial artery cuff oscillimetry blood pressure has fallen out of favor for
early prediction of cardiovascular mortality and several consensus statements have declared
pulse wave velocity and wave separation analysis more effective at predicting cardiovascular
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mortality in humans [127]. The major issue for preclinical and mechanistic biomedical re-
searchers is that there are not currently equivalent tools readily available to measure these
same parameters in rodent models for human disease, with wave separation analysis being the
most notable lack. Thus, the importance of developing and validating tools for biomedical
researchers to measure similar variables in rodents is of vital importance.
In this study, diastolic blood pressure increased with norepinephrine injection due to in-
crease in vasoconstriction in the periphery from stimulation of the arteriole α1 receptors.
Systolic blood pressure increased with norepinephrine injection as expected from increased
peripheral resistance and augmentation of the pressure pulse from earlier return of the back-
ward pressure wave [87]. Diastolic blood pressure decreased with sodium nitroprusside in-
jection due to vasodilation of the arterioles. Sodium nitroprusside breaks down into nitric
oxide within the circulatory system [31]. Nitric oxide induces vasodilation of the arterioles
by the arterial smooth muscle through activation of guanylyl cyclase and increased cGMP
production [31]. Systolic blood pressure decreased with sodium nitroprusside injection due to
a decrease in peripheral resistance and later arrival of the backward pressure wave. The ob-
served blood pressure changes were as expected for the vasoactive drug experiment protocol.
However, these blood pressure measurements do not reliably indicate arterial stiffness [127].
For that reason, clinicians have relied on other measures of arterial stiffness such as CA PSV
or pulse wave velocity.
We found that CA PSV did not increase with norepinephrine injections as expected and
did not decrease with sodium nitroprusside injections as expected. The opposite effect of
vasoactive injections cannot be explained by the confounding effect of pressure dependency
of CA PSV [111]. With the increase in pulse pressure seen with injection of a vasoconstrictor,
norepinephrine, we expect a higher CA PSV and with the decrease in pulse pressure seen
with injection of a vasodilator, sodium nitroprusside, we expect a lower CA PSV [111]. Pulse
wave velocity was evaluated indirectly through TT at the carotid artery, TT decreased with
norepinephrine as expected. However, TT also decreased with sodium nitroprusside which is
the opposite of what was predicted. This suggests that the rat carotid artery does not behave
as expected when vasoactive drugs are administered as an intravenous bolus. Additionally,
the segment of data chosen for analysis 30 seconds after the injection of vasoactive drugs may
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not represent the greatest treatment effect. This time frame for sampling was chosen based
on blood pressure changes in preliminary experiments but may not represent maximal arterial
stiffening. This study highlights that traditional measures of arterial stiffness, particularly
CA PSV and TT, a similar measurement to pulse wave velocity, are susceptible to other effects
that impair the ability to detect changes in arterial stiffness [72]. New robust measures of
arterial stiffness are needed for rodent cardiovascular research.
This study also provides reference ranges for characteristic impedance measured at the
carotid and femoral artery in rats, important values for biophysical studies such as this
that had not been previously determined in rats to our knowledge. The method of mea-
suring characteristic impedance in the femoral and carotid artery damages the endothelium
through catheter insertion [110]. Arterial stiffness will increase with damaged endothelium
theoretically increasing characteristic impedance [110]. An ex vivo theoretical measurement
of characteristic impedance in a section of rat carotid artery was of the same magnitude but
larger than the values measured in this study [25]. An in vivo measurement of characteristic
impedance in the rat aorta, 5200 ± 1200 dynes sec cm−5, was of the same magnitude as the
characteristic impedance measured at the carotid and femoral artery in this study [80]. The
similarity in characteristic impedance at the carotid and femoral artery to values previously
reported in the rat aorta increases the confidence in the method used to collect data and
the WSanalyze software. Aortic characteristic impedance has been used to explore the ef-
fects on the rat vasculature of nitric oxide, aging, left ventricular hypertrophy, hypertension,
calcification of arteries, chronic renal failure, and diabetes [44, 18, 20, 67, 24, 105]. Femoral
characteristic impedance did not vary enough to be used as a measure of arterial stiffness
in this acute vasoactive drug experiment. However, measuring wave reflection in this acute
vasoactive drug experiment was an indicator of arterial stiffness.
Wave reflection was assessed by reflection index and amplitude of the backward pressure
wave. Reflection index showed the expected trend of increasing with norepinephrine injection
and decreasing with sodium nitroprusside injection, but it was not a sensitive enough indi-
cator of arterial stiffness to be used alone. Reflection index is calculated using the forward
and backward pressure wave and the variation the forward pressure wave from the effect
of volume bolus drug administration on the heart may be a confounder in this experiment.
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The amplitude of the backward wave amplitude has been shown to be the most consistent
long-term wave separation analysis predictor independent of blood pressure of cardiovascu-
lar morbidity and mortality in humans [131]. Furthermore, the backward wave amplitude
has been shown to predict cardiovascular morbidity and mortality equally well in men and
women independent of pulse wave velocity; whereas reflection index has been only shown to
predict cardiovascular morbidity and mortality in men [128]. This study confirmed results
found in human clinical trials for preclinical rodent biomedical research; the amplitude of
the backward wave is the most sensitive wave separation analysis parameter measured by
WSanalyze for detecting arterial stiffness.
Norepinephrine injection caused an increase in the amplitude of the backward pressure
wave as expected from α1-mediated vasconstriction. There was no difference in the backward
pressure waves between sodium nitroprusside and saline injection. Because sodium nitroprus-
side is a nitric oxide donor, the vasodilatory effect it has may be masked by the vasodilation
caused by isoflurane [59]. Thus, the inability to detect a significant change in backward wave
amplitude after sodium nitroprusside injection in anesthetized rats is not taken as an indica-
tion of limitation of this parameter, but rather it is interpreted as detecting the underlying
lack of change in this parameter in a situation of vasodilation.
This study provides a new method measuring arterial stiffness in rats that is validated for
use with acute arterial stiffness changes induced by vasoactive drugs. Wave separation anal-
ysis in the femoral artery with WSanalyze can help researchers in determining the vascular
effect and mechanism of vasoactive drugs and may be equally successful if used in a chronic
model of cardiovascular disease that leads to arterial stiffness. The femoral artery measure-
ment of wave reflections validated in this study is technically easier than aortic measurement
of wave reflections. This technique provides a sensitive measure of arterial stiffness, backward
wave amplitude, for preclinical and mechanistic researchers that use rodents as models for
human disease.
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Chapter 5
Future Work and Conclusions
This thesis contributes to the development of new techniques of indicating and measuring
arterial stiffness in the rat. Two methods of measuring arterial stiffness were developed for
use in the femoral artery: pulse waveform analysis parameter dP/dtmin and wave separation
analysis. From the wave separation analysis parameters, the amplitude of the backward wave
is the most promising measure of arterial stiffness. The methods were developed by outlining
the surgical approaches to employ these new methods, describing the mathematical and
physical processing of calculating these new methods, and software development required
to analyze and report the measures of arterial stiffness from experimental data. Arterial
stiffness was induced in rats in chronic studies with varying levels of vitamin D. Additionally,
arterial stiffness was induced in rats in acute studies with vasoactive drug injections with
acetylcholine, norepinephrine, and sodium nitroprusside. The validity of the arterial stiffness
indices dP/dtmin, dP/dtmax, and backward wave amplitude, Zc, and RI were then compared
in these rat models of arterial stiffness. The most sensitive arterial stiffness indicies are
dP/dtmin, dP/dtmax, and backward wave amplitude for changes in arterial stiffness.
5.1 Summary of Results
5.1.1 Using dP/dtmin to Measure Arterial Stiffness in Rats
Pulse waveform analysis parameters were investigated using the rat femoral artery in Chapter
2 of this thesis. Implantation of blood pressure telemetry devices in the femoral artery pro-
vided continuous blood pressure monitoring capability for chronic hemodynamic experiments.
The femoral artery blood pressure trace shape can be analyzed into a set of cardiovascular
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parameters: systolic blood pressure, diastolic blood pressure, pulse pressure, dP/dtmin, and
dP/dtmax. The software PWanalyze was developed to calculate this set of parameters from
the measured blood pressure data. PWanalyze has a graphical user interface that is used
to input data files, select relevant areas of the blood pressure trace to be analyzed, and ex-
port the results in both textual and graphical formats. In the current study, varying levels
of vitamin D supplementation were fed chronically to rats. The range of arterial stiffness
produced was used to show that dP/dtmin was an equally good indicator of arterial stiffness
in comparison to dP/dtmax. A follow-up study with acute vasoactive drug injection showed
that the changes in dP/dtmin and dP/dtmax were consistent with an increase in arterial
stiffness caused by norepinephrine injection and a decrease in arterial stiffness caused by
acetylcholine injection. The performance of dP/dtmin was similar to dP/dtmax, but it may be
slightly better at detecting changes in chronic arterial stiffness because it varied significantly
with varying levels of vitamin D supplementation, whereas dP/dtmax did not. Biomedical
researchers should add dP/dtmin and dP/dtmax to their study any time intra-arterial blood
pressure is taken to gain valuable insight into arterial stiffness.
5.1.2 Using Wave Separation Analysis to Measure Arterial Stiff-
ness in Rats
Wave separation analysis was adapted to assess wave reflection in the rat peripheral arteries
in Chapter 4. The left and right carotid and femoral arteries were selected to develop a
peripheral artery wave separation analysis technique in the rat. A new adaptation of the
original wave separation analysis method to peripheral arteries was outlined. The indices
calculated by wave separation analysis include backward wave amplitude, Zc, and RI. The
custom software WSanalyze, was developed to calculate the wave separation analysis indices.
WSanalyze allows the user to specify an experimental data file and select relevant areas of
the blood pressure trace to analyze. Wave separation analysis indices are then are output in
graph and text form. An acute drug injection experiment using norepinephrine and sodium
nitroprusside demonstrated that backward waves could be observed in the femoral artery
using this new wave separation analysis adaptation. Backward waves could be seen to increase
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both qualitatively and quantitatively in the femoral artery with injection of norepinephrine.
The results from the new wave separation analysis adaptation agreed with the original wave
separation analysis method because the characteristic impedance calculated with the new
method was found to be of the same magnitude as aortic characteristic impedance and ex
vivo carotid artery characteristic impedance reported previously [25, 80]. Backward wave
amplitude is recommended for measuring arterial stiffness in the femoral artery of rats.
5.1.3 dP/dtmin Versus Backward Wave Amplitude
The measurement of dP/dtmin is recommended for every pre-clinical cardiovascular study
in rodents where the cardiovascular effects of disease, pharmaceuticals, or toxins are being
investigated through effects on blood pressure. The use of dP/dtmin has been validated
with intra-arterial blood pressure measurement in this study at the femoral and iliac artery.
Backward wave amplitude is the most sensitive indicator of arterial stiffness found in this
thesis. The use of backward wave amplitude has been validated at the femoral artery in rats
with paired measurement of flow at the right femoral artery and pressure at the left femoral
artery simultaneously.
Both dP/dtmin and backward wave amplitude have not been validated at locations other
than the femoral artery at this time. Measurement of dP/dtmin is easier than backward wave
amplitude because it only involves blood pressure measurement. This will enable researchers
to use blood pressure telemetry and measure dP/dtmin in conscious unrestrained animals,
whereas backward wave amplitude is measured in a terminal procedure under anesthesia
at this time. However, backward wave amplitude has been shown to be increasingly more
accurate in humans for predicting cardiovascular morbidity and mortality, and therefore, its
addition to pre-clinical rodent cardiovascular studies is invaluable. Backward wave ampli-
tude should be used by researchers to measure arterial stiffness in rats undergoing terminal
procedures and dP/dtmin should be used when measurement of backward wave amplitude is
impractical.
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5.2 Future Work
This section outlines future work that needs to be performed to strengthen the case for
femoral artery pulse waveform analysis and wave separation analysis to become accepted
measures of arterial stiffness in comparative biomedical studies.
5.2.1 Continuous rate infusion experiment
In Chapters 2 and 4, injection of vasoactive drugs was used to create acute changes in
arterial stiffness. The addition of the volume of the injection, called the volume bolus, has a
confounding effect on the experiment. The volume bolus increases the central venous pressure
which triggers the bainbridge reflex. The bainbridge reflex increases heart rate in response
to the increase of blood volume in the central veins. To filter out the volume bolus effect
in the current experiments, saline was injected in the same volume as the vasoactive drugs.
The saline injection was used to control for the volume bolus effect. However, the volume
bolus effect could be completely eliminated in future experiments if the vasoactive drugs were
given by continuous rate infusions. The vascular effects of bolus drug administration versus
a continuous rate infusion could then be characterized for pulse waveform analysis and wave
separation analysis in the rat peripheral arteries. Additionally, a continuous rate infusion
of vasoactive drugs would avoid the potential problem that the segment of data chosen for
analysis after the injection of vasoactive drugs may not represent the greatest treatment
effect. A continuous rate infusion experiment would establish how pulse waveform analysis
and wave separation analysis parameters vary with the bainbridge reflex and help future
researchers interpret pulse waveform analysis and wave separation analysis parameters when
a volume bolus is part of the experiment.
5.2.2 Characterization of pressure and heart rate dependency
Pressure and heart rate affect pulse wave velocity measurements. The effect of pressure
and heart rate on wave separation analysis parameters in the rat is not known, but it has
been assumed to be less than effects on pulse pressure or dP/dtmax [26, 33]. However, this
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assumption is untested. To investigate this further, a chronic arterial stiffening treatment
could be administered to the rats and then the blood pressure and heart rate could be
altered pharmacologically. The wave separation analysis parameters would then be compared
between the treated rats and the control rats at a variety of pressures and heart rates. This
would establish whether wave separation analysis must be compared at the same pressures
and heart rates to meaningfully compare arterial stiffness between different treatments and
offer further validation to these novel measures of arterial stiffness.
5.2.3 Comparison to central arterial dynamics
This thesis involves using wave separation analysis techniques in the femoral artery of the
rat. Wave separation analysis has been used by previous researchers in the aorta but not
the femoral artery. In order for wave separation analysis to be adopted in the femoral artery
as a standard technique, it must be shown that arterial stiffness measurements do not vary
between sites. To confirm that the femoral artery may be used to measure arterial stiffness,
backward waves should be compared between the ascending aorta and femoral artery in the
same rats under the same pathophysiological or pharmacological states. The ideal comparison
would be with a rat that does not need to be mechanically ventilated from a thoracotomy
during data collection. To achieve this, the blood pressure in the ascending aorta could be
measured by a blood pressure telemetry device introduced through the carotid artery. The
blood flow of the ascending aorta could be obtained by a chronic thoracotomy technique where
after placement of the flow probe, negative pleural pressure is re-established in the thorax
and the rat is recovered. Both surgical approaches for blood pressure and flow measurement
are possible and have been documented previously in rats. From this experiment, we would
be able to see the predictive power of wave separation analysis techniques in the femoral
artery of estimating the central arterial hemodynamics and general cardiovascular morbidity
and mortality.
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5.2.4 Comparison to the carotid artery
The femoral artery was used in this thesis to measure arterial stiffness with pulse waveform
analysis and wave separation analysis. The carotid artery might also be a suitable candidate
for peripheral artery measurement of arterial stiffness. Further work is needed to characterize
how pulse waveform analysis and wave separation analysis indices in the carotid artery vary
from the femoral artery. The carotid artery is involved in regulating blood flow to the brain,
which has controls that are often separate from the rest of the systemic circulation and
may be a confounding factor to the measurement of arterial stiffness in low blood pressure
states. Future work involves comparing the carotid artery to the femoral artery in rats
in hypotension, normotension, and hypertension. Currently, the femoral artery is the most
promising site for pulse waveform analysis and wave separation analysis; however, the carotid
artery may be a suitable alternative if the effects of blood pressure in the carotid artery are
fully investigated for pulse waveform analysis and wave separation analysis parameters.
5.2.5 Chronic arterial stiffening measurement
The goal of this study is to provide techniques that can be used in chronic arterial stiffening
studies. The natural extension of this research is to apply the methods of pulse waveform
analysis and wave separation analysis to rat models of atherosclerosis and chronic cardio-
vascular disease. In order for pulse waveform analysis and wave separation analysis to be
adapted as valuable tools by the biomedical research community, their utility in exploring the
effects of common diseases (i.e., high cholesterol, hypertension, and diabetes) on the arterial
system must be demonstrated.
5.3 Conclusion
All of the hypotheses in Section 1.7 were shown to be true. The theory behind wave sepa-
ration analysis was outlined and a peripheral artery technique for wave separation analysis
was developed. Open source software was developed to calculate dP/dtmin. Software was
also developed to calculate wave separation analysis and is available upon request. Acute
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and chronic experiments showed that dP/dtmin and backward wave amplitude are superior
measures of arterial stiffness.
With the results of the current thesis and further strengthening from the proposed future
experiments, pulse waveform analysis and wave separation analysis could become reliable,
important tools for preclinical cardiovascular researchers. By writing software and providing
free access to all researchers, the hope is to facilitate the uptake of this technology, improve
the quality of information provided in cardiovascular studies, and ultimately improve health
of all species, including humans.
74
References
[1] Ibhar Al Mheid, Riyaz Patel, Jonathan Murrow, Alanna Morris, Ayaz Rahman, Lucy
Fike, Nino Kavtaradze, Irina Uphoff, Craig Hooper, Vin Tangpricha, R Wayne Alexan-
der, Kenneth Brigham, and Arshed A Quyyumi. Vitamin D status is associated with
arterial stiffness and vascular dysfunction in healthy humans. Journal of the American
College of Cardiology, 58(2):186–92, jul 2011.
[2] Peter Alagona and Tariq Ali Ahmad. Cardiovascular disease risk assessment and pre-
vention: current guidelines and limitations. The Medical clinics of North America,
99(4):711–31, jul 2015.
[3] Kerstin Amann. Media calcification and intima calcification are distinct entities in
chronic kidney disease. Clinical journal of the American Society of Nephrology :
CJASN, 3(6):1599–605, nov 2008.
[4] Grethe Neumann Andersen, Lucia Mincheva-Nilsson, Elsadig Kazzam, Gunnar Nyberg,
Natalia Klintland, Ann-Sofi Petersson, Solbritt Rantapa¨a¨-Dahlqvist, Anders Walden-
stro¨m, and Kenneth Caidahl. Assessment of vascular function in systemic sclerosis:
indications of the development of nitrate tolerance as a result of enhanced endothelial
nitric oxide production. Arthritis and rheumatism, 46(5):1324–32, may 2002.
[5] David Ascher and Paul F Dubois. Numerical Python. Computers in Physics, 10:262–
267, 2001.
[6] Atcor Medical. Technical Note 9 Validation and Reproducibility of SphygmoCor Px.
[7] Jeffrey Atkinson. Age-related medial elastocalcinosis in arteries: mechanisms, animal
models, and physiological consequences. Journal of applied physiology (Bethesda, Md.
: 1985), 105(5):1643–51, nov 2008.
[8] Alberto Avolio. Input impedance of distributed arterial structures as used in investi-
gations of underlying concepts in arterial haemodynamics. Medical & biological engi-
neering & computing, 47(2):143–51, feb 2009.
[9] Alexandre Benjo, Richard E Thompson, Derek Fine, Charles W Hogue, Diane Alejo,
Anita Kaw, Gary Gerstenblith, Ashish Shah, Dan E Berkowitz, and Daniel Nyhan.
Pulse pressure is an age-independent predictor of stroke development after cardiac
surgery. Hypertension, 50(4):630–5, oct 2007.
75
[10] J. Blacher, B. Pannier, A. P. Guerin, S. J. Marchais, M. E. Safar, and G. M. London.
Carotid Arterial Stiffness as a Predictor of Cardiovascular and All-Cause Mortality in
End-Stage Renal Disease. Hypertension, 32(3):570–574, sep 1998.
[11] J M Bland and D G Altman. Measuring agreement in method comparison studies.
Statistical methods in medical research, 8(2):135–60, jun 1999.
[12] Mari E Boesen, Dilip Singh, Bijoy K Menon, and Richard Frayne. A systematic litera-
ture review of the effect of carotid atherosclerosis on local vessel stiffness and elasticity.
Atherosclerosis, 243(1):211–22, nov 2015.
[13] Barry A Borlaug and David A Kass. Invasive hemodynamic assessment in heart failure.
Heart failure clinics, 5(2):217–28, apr 2009.
[14] Mark Butlin, George Lindesay, Kayla D Viegas, and Alberto P Avolio. Pressure depen-
dency of aortic pulse wave velocity in vivo is not affected by vasoactive substances that
alter aortic wall tension ex vivo. American journal of physiology. Heart and circulatory
physiology, 308(10):H1221–8, may 2015.
[15] Marina Cecelja, Benyu Jiang, Karen McNeill, Bernet Kato, James Ritter, Tim Spector,
and Phil Chowienczyk. Increased wave reflection rather than central arterial stiffness
is the main determinant of raised pulse pressure in women and relates to mismatch
in arterial dimensions: a twin study. Journal of the American College of Cardiology,
54(8):695–703, aug 2009.
[16] K.-C. Chang, C.-D. Tseng, T.-F. Chou, Y.-L. Cho, T.-C. Chi, M.-J. Su, and Y.-Z.
Tseng. Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes.
European Journal of Clinical Investigation, 36(1):1–7, jan 2006.
[17] Kuo-Chu Chang, Kwan-Lih Hsu, Chuen-Den Tseng, Yue-Der Lin, Yi-Li Cho, and
Yung-Zu Tseng. Aminoguanidine prevents arterial stiffening and cardiac hypertrophy
in streptozotocin-induced diabetes in rats. British journal of pharmacology, 147(8):944–
50, apr 2006.
[18] Kuo-Chu Chang, Yuan-Feen Tsai, Chai-Yee Chow, Ying-I Peng, and Tong-J Chen. Age-
related changes of arterial mechanical properties in rats: analysis using exponentially
tapered T-tube model. The journals of gerontology. Series A, Biological sciences and
medical sciences, 53(4):B274–80, jul 1998.
[19] H I Chen and C T Hu. Endogenous nitric oxide on arterial hemodynamics: a comparison
between normotensive and hypertensive rats. The American journal of physiology,
273(4 Pt 2):H1816–23, oct 1997.
[20] H I Chen, C T Hu, and K C Chang. Characterization of arterial hemodynamics in
rats with established hypertension. The Chinese journal of physiology, 39(1):49–55,
jan 1996.
76
[21] Wei Chen, Shengxu Li, Camilo Fernandez, Dianjianyi Sun, Chin-Chih Lai, Tao Zhang,
Lydia Bazzano, Elaine M Urbina, and Hong-Wen Deng. Temporal Relationship Be-
tween Elevated Blood Pressure and Arterial Stiffening Among Middle-Aged Black
and White Adults: The Bogalusa Heart Study. American journal of epidemiology,
183(7):599–608, apr 2016.
[22] Tain-Junn Cheng, Jiunn-Jye Chuu, Chia-Yu Chang, Wan-Chen Tsai, Kuan-Jung Chen,
and How-Ran Guo. Atherosclerosis induced by arsenic in drinking water in rats through
altering lipid metabolism. Toxicology and applied pharmacology, 256(2):146–53, oct
2011.
[23] Yun-Seok Choi, Ho-Joong Youn, Jeong-Sook Youn, Chul-Soo Park, Yong-Seog Oh,
and Wook-Sung Chung. Measurement of the intimal thickness of the carotid artery:
comparison between 40 MHz ultrasound and histology in rats. Ultrasound in medicine
& biology, 35(6):962–6, jun 2009.
[24] Yao-Chen Chuang, Ming-Shiou Wu, Yi-Kai Su, and Kwang-Ming Fang. Effects of olme-
sartan on arterial stiffness in rats with chronic renal failure. Cardiovascular Diabetology,
11(1):66, jan 2012.
[25] R H Cox. Comparison of carotid artery mechanics in the rat, rabbit, and dog. The
American journal of physiology, 234(3):H280–8, mar 1978.
[26] Anthony M Dart and Bronwyn A Kingwell. Pulse pressurea review of mechanisms and
clinical relevance. Journal of the American College of Cardiology, 37(4):975–984, mar
2001.
[27] Claire de Oliveira, Van Hai Nguyen, Harindra C Wijeysundera, William W L Wong,
Gloria Woo, Peter P Liu, and Murray D Krahn. How much are we spending? The
estimation of research expenditures on cardiovascular disease in Canada. BMC health
services research, 12:281, jan 2012.
[28] Julius L Decano, Jason C Viereck, Ann C McKee, James A Hamilton, Nelson Ruiz-
Opazo, and Victoria L M Herrera. Early-life sodium exposure unmasks susceptibility
to stroke in hyperlipidemic, hypertensive heterozygous Tg25 rats transgenic for human
cholesteryl ester transfer protein. Circulation, 119(11):1501–9, mar 2009.
[29] D E Dick, J E Kendrick, G L Matson, and V C Rideout. Measurement of nonlinearity
in the arterial system of the dog by a new method. Circulation research, 22(2):101–11,
feb 1968.
[30] Stanley S Franklin, Sohum S Gokhale, Vincent H Chow, Martin G Larson, Daniel Levy,
Ramachandran S Vasan, Gary F Mitchell, and Nathan D Wong. Does low diastolic
blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease
events? The Framingham Heart Study. Hypertension, 65(2):299–305, feb 2015.
[31] J A Friederich and J F Butterworth. Sodium nitroprusside: twenty years and counting.
Anesthesia and analgesia, 81(1):152–62, jul 1995.
77
[32] Bala´zs Gaszner, Zso´fia Lenkey, Miklo´s Illye´s, Zsolt Sa´rszegi, Iva´n G Horva´th, Bala´zs
Magyari, Ferenc Molna´r, Attila Ko´nyi, and Attila Czira´ki. Comparison of aortic and
carotid arterial stiffness parameters in patients with verified coronary artery disease.
Clinical cardiology, 35(1):26–31, jan 2012.
[33] Nicole J Gentner and Lynn P Weber. Using blood pressure telemetry to assess acute
changes in arterial stiffness in rats after nitric oxide synthase inhibition or environ-
mental tobacco smoke exposure. Canadian journal of physiology and pharmacology,
88(9):918–28, sep 2010.
[34] Nicole J Gentner and Lynn P Weber. Intranasal benzo[a]pyrene alters circadian
blood pressure patterns and causes lung inflammation in rats. Archives of toxicology,
85(4):337–46, apr 2011.
[35] Nicole J Gentner and Lynn P Weber. Secondhand tobacco smoke, arterial stiffness,
and altered circadian blood pressure patterns are associated with lung inflammation
and oxidative stress in rats. American journal of physiology. Heart and circulatory
physiology, 302(3):H818–25, feb 2012.
[36] Edward G Grant, Carol B Benson, Gregory L Moneta, Andrei V Alexandrov, J Dennis
Baker, Edward I Bluth, Barbara A Carroll, Michael Eliasziw, John Gocke, Barbara S
Hertzberg, Sandra Katarick, Laurence Needleman, John Pellerito, Joseph F Polak,
Kenneth S Rholl, Douglas L Wooster, and Eugene Zierler. Carotid artery stenosis:
grayscale and Doppler ultrasound diagnosis–Society of Radiologists in Ultrasound con-
sensus conference. Ultrasound quarterly, 19(4):190–8, dec 2003.
[37] Heynric B Grotenhuis, Jos J M Westenberg, Paul Steendijk, Rob J van der Geest,
Jaap Ottenkamp, Jeroen J Bax, J Wouter Jukema, and Albert de Roos. Validation
and reproducibility of aortic pulse wave velocity as assessed with velocity-encoded MRI.
Journal of magnetic resonance imaging : JMRI, 30(3):521–6, sep 2009.
[38] Alvaro N Gurovich, Darren T Beck, and Randy W Braith. Aortic Pulse Wave Analysis
is not a surrogate for central arterial Pulse Wave Velocity. Experimental biology and
medicine (Maywood, N.J.), 234(11):1339–44, nov 2009.
[39] Evelien Hermeling, Arnold P G Hoeks, Mark H M Winkens, Johannes L Waltenberger,
Robert S Reneman, Abraham A Kroon, and Koen D Reesink. Noninvasive assessment
of arterial stiffness should discriminate between systolic and diastolic pressure ranges.
Hypertension, 55(1):124–30, jan 2010.
[40] Evelien Hermeling, Koen D Reesink, Arnold P G Hoeks, and Robert S Reneman.
Modeled decomposition of aortic pressure waveforms does not provide estimates for
pulse wave velocity. Hypertension, 51(6):e60; author reply e61, jun 2008.
[41] Victoria L Herrera, Julius L Decano, Nicholas Giordano, Ann Marie Moran, and Nelson
Ruiz-Opazo. Aortic and carotid arterial stiffness and epigenetic regulator gene expres-
sion changes precede blood pressure rise in stroke-prone Dahl salt-sensitive hypertensive
rats. PloS one, 9(9):e107888, jan 2014.
78
[42] H Higashino, K Simeonova, I Lambev, M Markov, and A Suzuki. Proper measure-
ment of blood pressure and heart rate in SHRSP and WKY by an indirect volume-
oscillometric method. Clinical and experimental pharmacology & physiology. Supple-
ment, 22(1):S292–3, dec 1995.
[43] C T Hu, K C Chang, C Y Wu, and H I Chen. Acute effects of nitric oxide blockade
with L-NAME on arterial haemodynamics in the rat. British journal of pharmacology,
122(6):1237–43, nov 1997.
[44] Cheng-Tao Hu, Huai-Ren Chang, Yung-Hsiang Hsu, Chia-Jui Liu, and Hsing I Chen.
Ventricular hypertrophy and arterial hemodynamics following deprivation of nitric ox-
ide in rats. Life sciences, 78(2):164–73, nov 2005.
[45] Yanwu Hu, Bo Sun, Kai Liu, Mengtong Yan, Yang Zhang, Chunsheng Miao, and
Liqun Ren. Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by
Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway. Inflammation,
aug 2015.
[46] Daniel A Huetteman and Heather Bogie. Direct blood pressure monitoring in laboratory
rodents via implantable radio telemetry. Methods in molecular biology (Clifton, N.J.),
573:57–73, jan 2009.
[47] John Hunter and Michael Droettboom. matplotlib. In The Architecture of Open Source
Applications, volume 2, pages 1–14. 2014.
[48] Jamila Ibrahim, Bradford C Berk, and Alun D Hughes. Comparison of simultaneous
measurements of blood pressure by tail-cuff and carotid arterial methods in conscious
spontaneously hypertensive and Wistar-Kyoto rats. Clinical and experimental hyper-
tension (New York, N.Y. : 1993), 28(1):57–72, jan 2006.
[49] David R Jacobs, Daniel A Duprez, and Daichi Shimbo. Invited Commentary: Hy-
pertension and Arterial Stiffness-Origins Remain a Dilemma. American journal of
epidemiology, 183(7):609–12, apr 2016.
[50] Gerard N. Jager, Nico Westerhof, and Abraham Noordergraaf. Oscillatory Flow
Impedance in Electrical Analog of Arterial System:: Representation of Sleeve Effect
and Non-Newtonian Properties of Blood. Circulation Research, 16(2):121–133, feb
1965.
[51] David Jegger, Rafaela da Silva, Xavier Jeanrenaud, Mohammad Nasratullah, Hendrik
Tevaearai, Ludwig K von Segesser, Patrick Segers, Virginie Gaillard, Jeffrey Atkinson,
Isabelle Lartaud, and Nikolaos Stergiopulo. Ventricular-arterial coupling in a rat model
of reduced arterial compliance provoked by hypervitaminosis D and nicotine. American
journal of physiology. Heart and circulatory physiology, 291(4):H1942–51, oct 2006.
[52] Hadassa M Jochemsen, Majon Muller, Michiel L Bots, Philip Scheltens, Koen L
Vincken, Willem P T M Mali, Yolanda van der Graaf, and Mirjam I Geerlings. Ar-
terial stiffness and progression of structural brain changes: The SMART-MR study.
Neurology, 84(5):448–55, feb 2015.
79
[53] Bernhard M Kaess, Jian Rong, Martin G Larson, Naomi M Hamburg, Joseph A Vita,
Daniel Levy, Emelia J Benjamin, Ramachandran S Vasan, and Gary F Mitchell. Aortic
stiffness, blood pressure progression, and incident hypertension. JAMA : the journal
of the American Medical Association, 308(9):875–81, sep 2012.
[54] Shin-ichiro Katsuda, Masamitsu Hasegawa, Masahiko Kusanagi, and Tsuyoshi Shimizu.
Comparison of pulse-wave velocity in different aortic regions in relation to the ex-
tent and severity of atherosclerosis between young and older Kurosawa and Kusanagi-
hypercholesterolemic (KHC) rabbits. Clinical science (London, England : 1979),
99(5):393–404, nov 2000.
[55] Pascal Kieffer, Alain Robert, Christine Capdeville-Atkinson, Jeffrey Atkinson, and
Isabelle Lartaud-Idjouadiene. Age-related arterial calcification in rats. Life sciences,
66(24):2371–81, may 2000.
[56] Mark J Kilgard. The opengl utility toolkit (glut) programming interface. 1996.
[57] Chang-Sei Kim, Nima Fazeli, M Sean McMurtry, Barry A Finegan, and Jin-Oh Hahn.
Quantification of wave reflection using peripheral blood pressure waveforms. IEEE
journal of biomedical and health informatics, 19(1):309–16, jan 2015.
[58] John G Kingma and P E Roy. Ultrastructural study of hypervitaminosis D induced
arterial calcification in Wistar rats. Artery, 16(1):51–61, jan 1988.
[59] P Kirstetter, F Lagneau, O Lucas, Y Krupa, and J Marty. Role of endothelium in the
modulation of isoflurane-induced vasodilatation in rat thoracic aorta. British Journal
of Anaesthesia, 79(1):84–87, 1997.
[60] S Kobayashi, M Yano, M Kohno, M Obayashi, Y Hisamatsu, T Ryoke, T Ohkusa,
K Yamakawa, and M Matsuzaki. Influence of aortic impedance on the development of
pressure-overload left ventricular hypertrophy in rats. Circulation, 94(12):3362–8, dec
1996.
[61] Satoru Kodama, Chika Horikawa, Kazuya Fujihara, Sakiko Yoshizawa, Yoko Yachi,
Shiro Tanaka, Nobumasa Ohara, Satoshi Matsunaga, Takaho Yamada, Osamu Hanyu,
and Hirohito Sone. Meta-analysis of the quantitative relation between pulse pressure
and mean arterial pressure and cardiovascular risk in patients with diabetes mellitus.
The American journal of cardiology, 113(6):1058–65, mar 2014.
[62] Ted R Kohler and Arkadiusz Jawien. Flow affects development of intimal hyperpla-
sia after arterial injury in rats. Arteriosclerosis, Thrombosis, and Vascular Biology,
12(8):963–971, aug 1992.
[63] Klaas Kramer and Rene´ Remie. Measuring blood pressure in small laboratory animals.
Methods in molecular medicine, 108:51–62, 2005.
[64] Eleanore S J Kro¨ner, Hildo J Lamb, Hans-Marc J Siebelink, Suzanne C Cannegieter,
Pieter J van den Boogaard, Ernst E van der Wall, Albert de Roos, and Jos J M
80
Westenberg. Pulse wave velocity and flow in the carotid artery versus the aortic arch:
effects of aging. Journal of magnetic resonance imaging : JMRI, 40(2):287–93, aug
2014.
[65] Theodore W Kurtz, Karen A Griffin, Anil K Bidani, Robin L Davisson, and John E
Hall. Recommendations for blood pressure measurement in humans and experimental
animals. Part 2: blood pressure measurement in experimental animals. Hypertension,
45:299–310, 2005.
[66] Pierre Lantelme, Christine Mestre, Michel Lievre, Alain Gressard, and Hugues Milon.
Heart rate: an important confounder of pulse wave velocity assessment. Hypertension,
39(6):1083–7, jun 2002.
[67] Isabelle Lartaud-Idjouadiene, Anne-Marie Lompre, Pascal Kieffer, The´re`se Colas, and
Jeffrey Atkinson. Cardiac Consequences of Prolonged Exposure to an Isolated Increase
in Aortic Stiffness. Hypertension, 34(1):63–69, jul 1999.
[68] Ste´phane Laurent, Pierre Boutouyrie, Roland Asmar, Isabelle Gautier, Brigette Laloux,
Louis Guize, Pierre Ducimetiere, and Athanase Benetos. Aortic Stiffness Is an Inde-
pendent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients.
Hypertension, 37(5):1236–1241, may 2001.
[69] Ste´phane Laurent, John Cockcroft, Luc Van Bortel, Pierre Boutouyrie, Cristina Gi-
annattasio, Daniel Hayoz, Bruno Pannier, Charalambos Vlachopoulos, Ian Wilkinson,
and Harry Struijker-Boudier. Expert consensus document on arterial stiffness: method-
ological issues and clinical applications. European heart journal, 27(21):2588–605, nov
2006.
[70] Ste´phane Laurent, John Cockcroft, Luc Van Bortel, Pierre Boutouyrie, Cristina Gi-
annattasio, Daniel Hayoz, Bruno Pannier, Charalambos Vlachopoulos, Ian Wilkinson,
and Harry Struijker-Boudier. Abridged version of the expert consensus document on
arterial stiffness. Artery Research, 1(1):2–12, jun 2007.
[71] Chen-Chin Lee and Rodger G Mark. Analysis of arterial waves by the single-pulse-
response method. IEEE transactions on bio-medical engineering, 40(8):833–6, aug 1993.
[72] Ching Wei Lee, Shih Hsien Sung, Chun Ku Chen, I Ming Chen, Hao Min Cheng,
Wen Chung Yu, Chun Che Shih, and Chen Huan Chen. Measures of carotid-femoral
pulse wave velocity and augmentation index are not reliable in patients with abdominal
aortic aneurysm. Journal of hypertension, 31(9):1853–60, sep 2013.
[73] Yan Li, Fang-Fei Wei, Shuai Wang, Yi-Bang Cheng, and Ji-Guang Wang. Cardiovas-
cular risks associated with diastolic blood pressure and isolated diastolic hypertension.
Current hypertension reports, 16(11):489, nov 2014.
[74] M L Lima, A I Fiorelli, D V Vassallo, P R Batista, F V Simoes, J Fiorim, I Stefanon,
B B Pinheiro, N A G Stolf, and O M Gomes. Deleterious effect of hypothermia in
myocardial protection against cold ischemia: a comparative study in isolated rat hearts.
Transplantation proceedings, 44(8):2326–32, oct 2012.
81
[75] Lien-Ying Lin, Yi-Chu Liao, Hsiu-Fen Lin, Yu-Shan Lee, Reuy-Tay Lin, Chung Y Hsu,
and Suh-Hang H Juo. Determinants of arterial stiffness progression in a Han-Chinese
population in Taiwan: a 4-year longitudinal follow-up. BMC cardiovascular disorders,
15(1):100, jan 2015.
[76] Giuseppe Mancia and Guido Grassi. Aggressive Blood Pressure Lowering Is Dangerous:
The J-Curve: Pro Side of the Argument. Hypertension, 63(1):29–36, nov 2013.
[77] Michael Markl, Wolf Wallis, Christoph Strecker, Beryl Primrose Gladstone, Werner
Vach, and Andreas Harloff. Analysis of pulse wave velocity in the thoracic aorta by flow-
sensitive four-dimensional MRI: reproducibility and correlation with characteristics in
patients with aortic atherosclerosis. Journal of magnetic resonance imaging : JMRI,
35(5):1162–8, may 2012.
[78] Susan A Marsh, Louis J Dell’italia, and John C Chatham. Interaction of diet and
diabetes on cardiovascular function in rats. American journal of physiology. Heart and
circulatory physiology, 296(2):H282–92, mar 2009.
[79] Marc W Merx, Cora Scha¨fer, Ralf Westenfeld, Vincent Brandenburg, Sylvia Hidajat,
Christian Weber, Markus Ketteler, and Willi Jahnen-Dechent. Myocardial stiffness,
cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient
mice. Journal of the American Society of Nephrology : JASN, 16(11):3357–64, nov
2005.
[80] G F Mitchell, M A Pfeffer, N Westerhof, and J M Pfeffer. Measurement of aortic input
impedance in rats. The American journal of physiology, 267(5 Pt 2):H1907–15, nov
1994.
[81] Gary F Mitchell, Marc A Pfeffer, Peter V Finn, and Janice M Pfeffer. Comparison of
techniques for measuring pulse-wave velocity in the rat. Journal of applied physiology
(Bethesda, Md. : 1985), 82(1):203–10, jan 1997.
[82] William E Moody, Nicola C Edwards, Colin D Chue, Charles J Ferro, and Jonathan N
Townend. Arterial disease in chronic kidney disease. Heart (British Cardiac Society),
99(6):365–72, mar 2013.
[83] Eric E Morgan, Andrew B Casabianca, Samer J Khouri, and Andrea L Nestor Kali-
noski. In vivo assessment of arterial stiffness in the isoflurane anesthetized sponta-
neously hypertensive rat. Cardiovascular ultrasound, 12:37, jan 2014.
[84] William J Mosley, Philip Greenland, Daniel B Garside, and Donald M Lloyd-Jones.
Predictive utility of pulse pressure and other blood pressure measures for cardiovascular
outcomes. Hypertension, 49(6):1256–64, jun 2007.
[85] Joseph P Murgo, Nico Westerhof, John P Giolma, and Stephen A Altobelli. Aortic
input impedance in normal man: relationship to pressure wave forms. Circulation,
62(1):105–116, jul 1980.
82
[86] Wilmer W Nichols. Cardiac output derived from the aortic pressure. PhD thesis,
Department of Physiology and Biophysics, University of Alabama, 1970.
[87] Wilmer W Nichols and David G Edwards. Arterial Elastance and Wave Reflection
Augmentation of Systolic Blood Pressure: Deleterious Effects and Implications for
Therapy. Journal of Cardiovascular Pharmacology and Therapeutics, 6(1):5–21, mar
2001.
[88] Wilmer W Nichols, Michael F O’Rourke, and Vlachopoulos Charalambos. McDonald’s
Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. Hodder
Arnold, London, 6th edition, 2011.
[89] Nathalie Niederhoffer, Isabelle Lartaud-Idjouadiene, Philippe Giummelly, Claude Du-
vivier, Rene´ Peslin, and Jeffrey Atkinson. Calcification of Medial Elastic Fibers and
Aortic Elasticity. Hypertension, 29(4):999–1006, apr 1997.
[90] William Noonan, Kristin Koch, Masaki Nakane, Junli Ma, Doug Dixon, Antoinette
Bolin, and Glenn Reinhart. Differential effects of vitamin D receptor activators on
aortic calcification and pulse wave velocity in uraemic rats. Nephrology, dialysis, trans-
plantation : official publication of the European Dialysis and Transplant Association -
European Renal Association, 23(12):3824–30, dec 2008.
[91] Michael F O’Rourke. Arterial aging: pathophysiological principles. Vascular medicine
(London, England), 12(4):329–41, nov 2007.
[92] Michael F O’Rourke and Junichiro Hashimoto. Mechanical factors in arterial aging:
a clinical perspective. Journal of the American College of Cardiology, 50(1):1–13, jul
2007.
[93] Michael F O’Rourke, Jan A Staessen, Charalambos Vlachopoulos, Daniel Duprez, and
Ge´rard E Plante. Clinical applications of arterial stiffness; definitions and reference
values. American journal of hypertension, 15(5):426–44, may 2002.
[94] Anna Paini, Pierre Boutouyrie, David Calvet, Anne-Isabelle Tropeano, Brigitte Laloux,
and Ste´phane Laurent. Carotid and aortic stiffness: determinants of discrepancies.
Hypertension, 47(3):371–6, mar 2006.
[95] Subramani Parasuraman and Ramasamy Raveendran. Measurement of invasive blood
pressure in rats. Journal of pharmacology & pharmacotherapeutics, 3(2):172–7, apr
2012.
[96] Marie¨lle M F Poels, Ke`ren Zaccai, Germaine C Verwoert, Meike W Vernooij, Al-
bert Hofman, Aad van der Lugt, Jacqueline C M Witteman, Monique M B Breteler,
Francesco U S Mattace-Raso, and M Arfan Ikram. Arterial stiffness and cerebral small
vessel disease: the rotterdam scan study. Stroke; a journal of cerebral circulation,
43(10):2637–42, oct 2012.
[97] J D Pruett, J D Bourland, and L A Geddes. Measurement of pulse-wave velocity using
a beat-sampling technique. Annals of biomedical engineering, 16(4):341–7, jan 1988.
83
[98] Ahmed Qasem and Alberto Avolio. Determination of aortic pulse wave velocity from
waveform decomposition of the central aortic pressure pulse. Hypertension, 51(2):188–
95, feb 2008.
[99] Karen Quirk and Dennis F Bandyk. Interpretation of carotid duplex testing. Seminars
in vascular surgery, 26(2-3):72–85, jan 2013.
[100] R Core Team. R: A Language and Environment for Statistical Computing. R Founda-
tion for Statistical Computing, Vienna, Austria, 2014.
[101] S W Rabkin and A Y Fung. Increased sensitivity to norepinephrine cardiac arrhyth-
mias in the deoxycorticosterone acetate high salt rat before the onset of hypertension.
Canadian journal of physiology and pharmacology, 62(6):605–9, jun 1984.
[102] Noel Rappin and Robin Dunn. wxPython in Action. mar 2006.
[103] James C Russell and Spencer D Proctor. Small animal models of cardiovascular disease:
tools for the study of the roles of metabolic syndrome, dyslipidemia, and atheroscle-
rosis. Cardiovascular pathology : the official journal of the Society for Cardiovascular
Pathology, 15(6):318–30, jan 2006.
[104] Gale H Rutan, Robert H McDonald, and Lewis H Kuller. A historical perspective of
elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial
viewpoint. Journal of clinical epidemiology, 42(7):663–73, jan 1989.
[105] Sangeetha Satheesan, J L Figarola, T Dabbs, S Rahbar, and R Ermel. Effects of a new
advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving
arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
British journal of pharmacology, 171(12):3103–14, jun 2014.
[106] Patrick Segers, Ernst R Rietzschel, Marc L De Buyzere, Dirk De Bacquer, Luc M
Van Bortel, Guy De Backer, Thierry C Gillebert, and Pascal R Verdonck. Assess-
ment of pressure wave reflection: getting the timing right! Physiological measurement,
28(9):1045–56, sep 2007.
[107] Robert E Shadwick. Mechanical design in arteries. J. Exp. Biol., 202(23):3305–3313,
dec 1999.
[108] James E Sharman, Thomas H Marwick, Deborah Gilroy, Petr Otahal, Walter P Abha-
yaratna, and Michael Stowasser. Randomized trial of guiding hypertension management
using central aortic blood pressure compared with best-practice care: principal findings
of the BP GUIDE study. Hypertension, 62(6):1138–45, dec 2013.
[109] Dave Shreiner and The Khronos OpenGL ARB Working Group. OpenGL Programming
Guide: The Official Guide to Learning OpenGL, Versions 3.0 and 3.1. jul 2009.
[110] P Sobolewski and M El Fray. Cardiac catheterization: consequences for the endothe-
lium and potential for nanomedicine. Wiley interdisciplinary reviews. Nanomedicine
and nanobiotechnology, 7(3):458–73.
84
[111] E Brooke Spencer, Douglas H Sheafor, Barbara S Hertzberg, James D Bowie, Rendon C
Nelson, Barbara A Carroll, and Mark A Kliewer. Nonstenotic internal carotid arter-
ies: effects of age and blood pressure at the time of scanning on Doppler US velocity
measurements. Radiology, 220(1):174–8, jul 2001.
[112] Jan A Staessen, Jerzy Gasowski, Ji G Wang, Lutgarde Thijs, Elly Den Hond, Jean-
Pierre Boissel, John Coope, Tork Ekbom, Franc¸ois Gueyffier, Lisheng Liu, Karla Ker-
likowske, Stuart Pocock, and Robert H Fagard. Risks of untreated and treated isolated
systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet (London,
England), 355(9207):865–72, mar 2000.
[113] Jan A Staessen, Ji-Guang Wang, and Lutgarde Thijs. Cardiovascular protection and
blood pressure reduction: a meta-analysis. The Lancet, 358(9290):1305–1315, oct 2001.
[114] Jun Sugawara, Hidehiko Komine, Koichiro Hayashi, Seiji Maeda, and Mitsuo Matsuda.
Relationship between augmentation index obtained from carotid and radial artery pres-
sure waveforms. Journal of hypertension, 25(2):375–81, feb 2007.
[115] Isabella Tan, Mark Butlin, Ying Yi Liu, Keith Ng, and Alberto P Avolio. Heart
rate dependence of aortic pulse wave velocity at different arterial pressures in rats.
Hypertension, 60(2):528–33, aug 2012.
[116] Jean-Michel Tartie`re, Jean-Yves Tabet, Damien Logeart, Lamia Tartie`re-Kesri, Flo-
rence Beauvais, Christophe Chavelas, and Alain Cohen Solal. Noninvasively determined
radial dP/dt is a predictor of mortality in patients with heart failure. American heart
journal, 155(4):758–63, apr 2008.
[117] Michael G Taylor. An Approach to an Analysis of the Arterial Pulse Wave I. Oscillations
in an Attenuating Line. Physics in Medicine and Biology, 1(3):258–269, jan 1957.
[118] Michael G Taylor. An Approach to an Analysis of the Arterial Pulse Wave II. Fluid
Oscillations in an Elastic Pipe. Physics in Medicine and Biology, 1(4):321–329, apr
1957.
[119] M Tjepkema, R Wilkins, N Goedhuis, and J Pennock. Cardiovascular disease mortality
among First Nations people in Canada, 1991-2001. Chronic diseases and injuries in
Canada, 32(4):200–7, sep 2012.
[120] Vitor E Valenti, Luiz Carlos de Abreu, Hugo Macedo Junior, Oseas F Moura Filho,
and Celso Ferreira. Baroreflex sensitivity differs among same strain Wistar rats from
the same laboratory. Heart international, 6(2):e9, jan 2011.
[121] Nicole M van Popele, Diederick E Grobbee, Michiel L Bots, Roland Asmar, Jirar
Topouchian, Robert S Reneman, Arnold P G Hoeks, Deidre A M van der Kuip, Albert
Hofman, and Jacqueline C M Witteman. Association Between Arterial Stiffness and
Atherosclerosis : The Rotterdam Study. Stroke, 32(2):454–460, feb 2001.
[122] Guido Van Rossum and Fred L Drake Jr. Python reference manual. Centrum voor
Wiskunde en Informatica Amsterdam, 1995.
85
[123] Thomas T van Sloten, Miranda T Schram, Katja van den Hurk, Jacqueline M Dekker,
Giel Nijpels, Ronald M A Henry, and Coen D A Stehouwer. Local stiffness of the
carotid and femoral artery is associated with incident cardiovascular events and all-
cause mortality: the Hoorn study. Journal of the American College of Cardiology,
63(17):1739–47, may 2014.
[124] Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Marta Garofoli, and Gianpaolo
Reboldi. Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve: Con Side of
the Argument. Hypertension, 63(1):37–40, nov 2013.
[125] Charalambos Vlachopoulos, Konstantinos Aznaouridis, Michael F O’Rourke, Michel E
Safar, Katerina Baou, and Christodoulos Stefanadis. Prediction of cardiovascular events
and all-cause mortality with central haemodynamics: a systematic review and meta-
analysis. European heart journal, 31(15):1865–71, aug 2010.
[126] Charalambos Vlachopoulos, Konstantinos Aznaouridis, and Christodoulos Stefanadis.
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a
systematic review and meta-analysis. Journal of the American College of Cardiology,
55(13):1318–27, mar 2010.
[127] Charalambos Vlachopoulos, Panagiotis Xaplanteris, Victor Aboyans, Marianne Brod-
mann, Renata C´ıfkova´, Francesco Cosentino, Marco De Carlo, Augusto Gallino, Ulf
Landmesser, Ste´phane Laurent, John Lekakis, Dimitri P Mikhailidis, Katerina K Naka,
Athanasios D Protogerou, Damiano Rizzoni, Arno Schmidt-Trucksa¨ss, Luc Van Bor-
tel, Thomas Weber, Akira Yamashina, Reuven Zimlichman, Pierre Boutouyrie, John
Cockcroft, Michael O’Rourke, Jeong Bae Park, Giuseppe Schillaci, Henrik Sillesen, and
Raymond R Townsend. The role of vascular biomarkers for primary and secondary pre-
vention. A position paper from the European Society of Cardiology Working Group on
peripheral circulation: Endorsed by the Association for Research into Arterial Structure
and Physiology (ARTERY. Atherosclerosis, 241(2):507–32, aug 2015.
[128] Kang-Ling Wang, Hao-Min Cheng, Shih-Hsien Sung, Shao-Yuan Chuang, Cheng-Hung
Li, Harold A Spurgeon, Chih-Tai Ting, Samer S Najjar, Edward G Lakatta, Frank
C P Yin, Pesus Chou, and Chen-Huan Chen. Wave reflection and arterial stiffness in
the prediction of 15-year all-cause and cardiovascular mortalities: a community-based
study. Hypertension, 55(3):799–805, mar 2010.
[129] Y Wang, J N Yang, A Arner, P J M Boels, and B B Fredholm. Adenosine A(1)
receptors and vascular reactivity. Acta physiologica (Oxford, England), 199(2):211–20,
jun 2010.
[130] Thomas Weber, Siegfried Wassertheurer, Martin Rammer, Anton Haiden, Bernhard
Hametner, and Bernd Eber. Wave reflections, assessed with a novel method for pulse
wave separation, are associated with end-organ damage and clinical outcomes. Hyper-
tension, 60(2):534–41, aug 2012.
[131] Thomas Weber, Siegfried Wassertheurer, Martin Rammer, Anton Haiden, Bernhard
Hametner, and Bernd Eber. Wave reflections, assessed with a novel method for pulse
86
wave separation, are associated with end-organ damage and clinical outcomes. Hyper-
tension, 60(2):534–41, aug 2012.
[132] Berend E Westerhof, Ilja Guelen, Nico Westerhof, John M Karemaker, and Alberto
Avolio. Quantification of wave reflection in the human aorta from pressure alone: a
proof of principle. Hypertension, 48(4):595–601, oct 2006.
[133] N Westerhof, P Sipkema, G C van den Bos, and G Elzinga. Forward and backward
waves in the arterial system. Cardiovascular research, 6(6):648–56, nov 1972.
[134] Nico Westerhof and P Sipkema. Measurement of pulse wave velocity using a beat-
sampling technique. Annals of biomedical engineering, 17(3):309–11, jan 1989.
[135] Nico Westerhof, Nikos Stergiopulos, and Mark I.M. Noble. Snapshots of Hemodynamics,
volume 18 of Basic Science for the Cardiologist. Kluwer Academic Publishers, Boston,
2005.
[136] Seamus P Whelton, Ron Blankstein, Mouaz H Al-Mallah, Joao A C Lima, David A
Bluemke, W Gregory Hundley, Joseph F Polak, Roger S Blumenthal, Khurram Nasir,
and Michael J Blaha. Association of resting heart rate with carotid and aortic arterial
stiffness: multi-ethnic study of atherosclerosis. Hypertension, 62(3):477–84, sep 2013.
[137] Wenxin Xu, Saveli I Goldberg, Maria Shubina, and Alexander Turchin. Optimal systolic
blood pressure target, time to intensification, and time to follow-up in treatment of
hypertension: population based retrospective cohort study. BMJ (Clinical research
ed.), 350:h158, jan 2015.
[138] Jieyun You, Jian Wu, Junbo Ge, and Yunzeng Zou. Comparison between adenosine
and isoflurane for assessing the coronary flow reserve in mouse models of left ventricular
pressure and volume overload. American journal of physiology. Heart and circulatory
physiology, 303(10):199–207, sep 2012.
[139] Susan J Zieman, Vojtech Melenovsky, and David A Kass. Mechanisms, pathophysiol-
ogy, and therapy of arterial stiffness. Arteriosclerosis, thrombosis, and vascular biology,
25(5):932–43, may 2005.
[140] Armin Zittermann, Stefanie S Schleithoff, and Reiner Koerfer. Vitamin D and vascular
calcification. Current opinion in lipidology, 18(1):41–6, feb 2007.
87
Appendix A
Representing the arterial system as a trans-
mission line
A transmission line is an electrical circuit component that is designed to carry high
frequency alternating current. Wave separation analysis, WSA, is based on modeling the
arterial system as a transmission line carrying an alternating current. Figure A.1 shows
the simplest example of a transmission line that consists of two wires of infinite length
running in parallel as part of a larger circuit that carries alternating current. The behavior
of the transmission line in Figure A.1 can be described by a single real parameter called
characteristic impedance Zc assuming the wires are uniform, have no loss of power, and are
of infinite length. If there are discontinuities in the transmission line, the alternating current
is reflected back to the source.
i(z,t)
i(z,t)
+
−
V (z,t)
Figure A.1: A simple linear transmission line represented as two wires of infinite
length. At a distance z along the wire from some origin, there is an alternating cur-
rent sinusoidal wave of i(z, t) travelling through each wire, and this creates a voltage
difference of V (z, t). With a single wave traveling through the wire and no reflections
produced at the end of the transmission line, the system is decribed by the character-
istic impedance Zc = V (z, t)/i(z, t). The characteristic impedance is purely real and
does not depend on z in a uniform wire that is lossless.
The transmission line model describing a segment of artery is shown in Figure A.2. The
inductor L resists changes in electrical current passing through it. The resistor R reduces the
current and voltage levels in the circuit. The capacitor C stores energy in an electrostatic
field between its plates. The telegraph equations describing the transmission line model of
the arterial system are given by Equations A.1 and A.2.
88
−∂V
∂z
= L′
∂i
∂t
+R′i, (A.1)
− ∂i
∂z
= C ′
∂V
∂t
+
V
R′l
, (A.2)
where z is distance, t is time, V = V (z, t) is voltage, L′ is inductance per unit length, C ′ is
capacitance per unit length, i = i(z, t) is current, R′ resistance per unit length, and 1
R′l
is the
leakage per length [50].
L′ R′
C ′
i
−
+
V Rli
Figure A.2: Transmission model of an arterial segment of length δz. L′ is inductance
per length, C ′ is capacitance per length, i , i(z, t) is current, R′ resistance per length,
Rl , R
′
l
δz
where 1
R′l
is the conductance per unit length, and V , V (z, t) is voltage [50].
The linearized Navier Stokes equations that describe the blood flow, Q, and pressure,
P , in a short segment of artery with a constant cross-sectional area and homogeneous and
isotropic wall material are as follows:
−∂P
∂z
=
ρ
S
∂Q
∂t
+WQ (A.3)
−∂Q
∂z
=
∂S
∂P
∂P
∂t
+Gp (A.4)
where P = P (z, t) is pressure, z is the position, S is the cross-sectional area, ρ is the density
of blood, ρ
S
is the inertia per unit length, Q = Q(x, t) is flow, t is time, W is friction per unit
length, G is the leakage per unit length, and ∂S
∂P
is the distensibility per unit length.
The telegraph equations are mathematically equivalent to the linearized Navier Stokes
equations via the associations of flow with current, pressure with voltage, inertia with induc-
tance, friction with resistance, distensibility with capacitance, and leakage G with 1
R′l
[50].
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Appendix B
Fourier Analysis
The coefficients a0, an, and bn, n ∈ Z+ for the Fourier series harmonics of angular fre-
quency w are computed for a single waveform g(x):
g(x) = a0 +
∞∑
n=1
an cos(nωx) +
∞∑
n=1
bn sin(nωx), (B.1)
where w = 2pif , f = 1
t2−t1 , t1 is the beginning of a cardiac cycle, and t2 is the end of the same
cardiac cycle. Note that t2− t1 corresponds to the period of the cardiac cycle. Equation B.1
can be solved for a0 when multiplied by 1, which is the basis function for a0, and integrated
over the domain t1 to t2,
t2∫
t1
g(x)dx = a0
t2∫
t1
1dx+
∞∑
n=1
an
t2∫
t1
cos(nωx)dx+
∞∑
n=1
bn
t2∫
t1
sin(nωx)dx.
The trignometric integrals over the domain t1 to t2 are:
t2∫
t1
cos(nωx)dx = 0,
t2∫
t1
sin(nωx)dx = 0,
and the coefficient a0 can be solved for:
a0 =
t2∫
t1
g(x)dx
(t2 − t1) . (B.2)
Equation B.1 can be solved for am for an arbitrary m ∈ Z+ by multiplying both sides of
equation B.1 by the basis function cos(mωx),
t2∫
t1
g(x) cos(mωx)dx = a0
t2∫
t1
cos(mωx)dx+
∞∑
n=1
an
t2∫
t1
cos(nωx) cos(mωx)dx
+
∞∑
n=1
bn
t2∫
t1
sin(nωx) cos(mωx)dx.
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The trigonometric integrals over the domain t1 to t2 are:
t2∫
t1
cos(mωx)dx = 0,
t2∫
t1
cos(nωx) cos(mωx)dx = 0 when n 6= m,
t2∫
t1
cos(nωx) cos(mωx)dx =
t2∫
t1
cos2(mωx)dx =
t2 − t1
2
when n = m,
t2∫
t1
sin(nωx) cos(mωx)dx = 0.
The coefficient am can then be solved for:
am =
2
t2∫
t1
g(x) cos(mωx)dx
t2 − t1 . (B.3)
Equation B.1 can be solved for bm for an arbitrary m ∈ Z+ by multiplying both sides of
equation B.1 by the basis function sin(mωx),
t2∫
t1
g(x) sin(mωx)dx = a0
t2∫
t1
sin(mωx)dx+
∞∑
n=1
an
t2∫
t1
cos(nωx) sin(mωx)dx
+
∞∑
n=1
bn
t2∫
t1
sin(nωx) sin(mωx)dx.
The trigonometric integrals over the domain t1 to t2 are:
t2∫
t1
sin(mωx)dx = 0,
t2∫
t1
cos(nωx) sin(mωx)dx = 0
t2∫
t1
sin(nωx) sin(mωx)dx = 0 when n 6= m,
t2∫
t1
sin(nωx) sin(mωx)dx =
t2∫
t1
sin2(mωx)dx =
t2 − t1
2
when n = m.
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The coefficients bm can then be solved for:
bm =
2
t2∫
t1
g(x) sin(mωx)dx
t2 − t1 . (B.4)
Using trignometric identities, the coefficients can be converted into the phase angle form
that is traditionally used for wave separation analysis [88]:
g(x) = a0 +
∞∑
n=1
cn cos(nωx+ ϕn),
cn =
√
a2n + b
2
n,
ϕn = arctan
(
− bn
an
)
,
where cn is the amplitude and ϕn is the phase angle.
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Appendix C
Phasor Arithmetic
The phase angle form of the Fourier Series can be transformed into a phasor that is
represented as a complex number.
|Mn| cos(ωnt+ ϕn) = Re
{|Mn| ei(ωnt+ϕ)}
where n is a particular harmonic of the fourier series, Mn is the modulus of the fourier series
nth harmonic, ω is the angular frequency, andϕn is the phase shift of the fourier series nth
harmonic.
The phasor form is simplified for addition, subtraction, multiplication, and division of
sinusoids with the same angular frequency, ω, and harmonic, n. Once simplified, the phasors
can be expressed in exponential phasor form (equation C.1), in rectangular phasor form
(equation C.2), and in phasor notation (equation C.3).
z = |M | eiϕ (C.1)
= A+ iB (C.2)
= |M |∠ϕ (C.3)
Multiplication of two phasors involves multiplying their moduli and adding together their
phases (equation C.4). Division of two phasors involves dividing their moduli and subtracting
their phases (equation C.5).
z1 = M1∠ϕ1
z2 = M2∠ϕ2
z1 × z2 = M1 ×M2∠ϕ1+ϕ2 (C.4)
z1
z2
=
M1
M2∠ϕ1−ϕ2
(C.5)
Addition (Equation C.6) and subtraction (Equation C.7) of phasors occurs after being
converted into rectangular form.
A = |M | cos(ϕ)
B = |M | sin(ϕ)
z1 = A1 + iB1
z2 = A2 + iB2
z1 + z2 = (A1 + A2) + i(B1 +B2) (C.6)
z1 − z2 = (A1 − A2) + i(B1 −B2) (C.7)
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The rectangular form can be converted back into exponential form by:
M =
√
A2 +B2,
ϕ = arctan(
B
A
).
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